Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileMark Barry Abelson IV, M.D.,C.M.

TitleProfessor of Ophthalmology, Part-time
InstitutionSchepens Eye Research Institute
DepartmentOphthalmology
Address138 Haverhill Street
Andover MA 01810
Phone978/475-0705
Fax978/475-0008
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rodriguez JD, Lane KJ, Ousler GW, Angjeli E, Smith LM, Abelson MB. Blink: Characteristics, Controls, and Relation to Dry Eyes. Curr Eye Res. 2017 Oct 18; 1-15. PMID: 29043838.
    View in: PubMed
  2. Ousler GW, Rimmer D, Smith LM, Abelson MB. Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review. Ophthalmol Ther. 2017 Sep 27. PMID: 28956287.
    View in: PubMed
  3. Corcoran P, Hollander DA, Ousler GW, Angjeli E, Rimmer D, Lane K, Abelson MB. Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects. J Ocul Pharmacol Ther. 2017 Nov; 33(9):686-692. PMID: 28933582.
    View in: PubMed
  4. Angjeli E, Gomes P, Lane KJ, Stein L, Abelson MB. Technical and clinical validation of the Allergen BioCube® for timothy grass. Immun Inflamm Dis. 2017 Mar; 5(1):78-84. PMID: 28250927.
    View in: PubMed
  5. Torkildsen G, Abelson MB, Gomes PJ, McLaurin E, Potts SL, Mah FS. Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model. J Ocul Pharmacol Ther. 2017 Mar; 33(2):79-90. PMID: 28072552.
    View in: PubMed
  6. Gomes PJ, Lane KJ, Angjeli E, Stein L, Abelson MB. Technical and clinical validation of an environmental exposure unit for ragweed. J Asthma Allergy. 2016; 9:215-221. PMID: 28008277.
    View in: PubMed
  7. Zuberbier T, Abelson MB, Akdis CA, Bachert C, Berger U, Bindslev-Jensen C, Boelke G, Bousquet J, Canonica GW, Casale TB, Jutel M, Kowalski ML, Madonini E, Papadopoulos NG, Pfaar O, Sehlinger T, Bergmann KC. Validation of the Global Allergy and Asthma European Network (GA2LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber. J Allergy Clin Immunol. 2017 Apr; 139(4):1158-1166. PMID: 27697498.
    View in: PubMed
  8. Rodriguez JD, Lane KJ, Ousler GW, Angjeli E, Smith LM, Bateman KM, Abelson MB. Diurnal Tracking of Blink and Relationship to Signs and Symptoms of Dry Eye. Cornea. 2016 Aug; 35(8):1104-11. PMID: 27261939.
    View in: PubMed
  9. Ousler GW, Rodriguez JD, Smith LM, Lane KJ, Heckley C, Angjeli E, Abelson MB. Optimizing Reading Tests for Dry Eye Disease. Cornea. 2015 Aug; 34(8):917-21. PMID: 26075460.
    View in: PubMed
  10. Abelson MB, Shetty S, Korchak M, Butrus SI, Smith LM. Advances in pharmacotherapy for allergic conjunctivitis. Expert Opin Pharmacother. 2015 Jun; 16(8):1219-31. PMID: 25943976.
    View in: PubMed
  11. Rodriguez JD, Lane KJ, Ousler GW, Angjeli E, Smith LM, Abelson MB. Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye. Invest Ophthalmol Vis Sci. 2015 Apr; 56(4):2340-7. PMID: 26066593.
    View in: PubMed
  12. Rodriguez JD, Lane K, Ousler GW, Angjeli E, Smith L, Abelson M. Automated Grading System for Evaluation of Corneal Superficial Punctate Keratitis Associated with Dry Eye. Invest Ophthalmol Vis Sci. 2015 Mar 03. PMID: 25736787.
    View in: PubMed
  13. Ousler GW, Abelson MB, Johnston PR, Rodriguez J, Lane K, Smith LM. Blink patterns and lid-contact times in dry-eye and normal subjects. Clin Ophthalmol. 2014; 8:869-74. PMID: 24833893; PMCID: PMC4015796.
  14. Rodriguez JD, Johnston PR, Ousler GW, Smith LM, Abelson MB. Automated grading system for evaluation of ocular redness associated with dry eye. Clin Ophthalmol. 2013; 7:1197-1204. PMID: 23814457; PMCID: PMC3693861.
  15. Abelson M. Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience. Cardiovasc J Afr. 2013 May; 24(4):107-9. PMID: 24217039; PMCID: PMC3721860.
  16. Rodriguez JD, Ousler GW, Johnston PR, Lane K, Abelson MB. Investigation of extended blinks and interblink intervals in subjects with and without dry eye. Clin Ophthalmol. 2013; 7:337-42. PMID: 23439943; PMCID: PMC3577009.
  17. Johnston PR, Rodriguez J, Lane KJ, Ousler G, Abelson MB. The interblink interval in normal and dry eye subjects. Clin Ophthalmol. 2013; 7:253-9. PMID: 23403736; PMCID: PMC3565584.
  18. Gomes PJ, Ousler GW, Welch DL, Smith LM, Coderre J, Abelson MB. Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy. Clin Ophthalmol. 2013; 7:157-65. PMID: 23378734; PMCID: PMC3553653.
  19. Williams JI, Kennedy KS, Gow JA, Torkildsen GL, Abelson MB, Gomes PJ, McNamara TR. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis. J Ocul Pharmacol Ther. 2011 Aug; 27(4):385-93. PMID: 21649522.
    View in: PubMed
  20. Abelson MB, McLaughlin JT, Gomes PJ. Antihistamines in ocular allergy: are they all created equal? Curr Allergy Asthma Rep. 2011 Jun; 11(3):205-11. PMID: 21437647.
    View in: PubMed
  21. Abelson MB, Maffei C, Dewey-Mattia D. The Secrets to Sustained Release. Review of Ophthalmology. 2010; 17(1):38-40.
  22. Abelson M, Roos J. Mechanical embolectomy for large vessel ischemic strokes: a cardiologist's experience. Catheter Cardiovasc Interv. 2010 Sep 01; 76(3):309-15. PMID: 20506287.
    View in: PubMed
  23. Abelson MB. Personal profile. Mark B. Abelson, MD, CM, FRCSC. Ocul Surf. 2010 Jul; 8(3):154-6. PMID: 20712972.
    View in: PubMed
  24. Torkildsen GL, Williams JI, Gow JA, Gomes PJ, Abelson MB, McNamara TR. Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge. Ann Allergy Asthma Immunol. 2010 Jul; 105(1):57-64. PMID: 20642205.
    View in: PubMed
  25. Walker PM, Lane KJ, Ousler GW, Abelson MB. Diurnal variation of visual function and the signs and symptoms of dry eye. Cornea. 2010 Jun; 29(6):607-12. PMID: 20458235.
    View in: PubMed
  26. Macejko TT, Bergmann MT, Williams JI, Gow JA, Gomes PJ, McNamara TR, Abelson MB. Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis. Am J Ophthalmol. 2010 Jul; 150(1):122-127.e5. PMID: 20488431.
    View in: PubMed
  27. Maffei CJ, Ousler III GW, Welch DL, Curwen SJ, Prifogle E, Abelson MB. Time to reflex tearing in response to chemical nasolacrimal stimulus in dry eye subjects versus normals. Association for Research in Vision and Ophthalmology Meeting. 2010.
  28. Angjeli E, Rodriguez J, Lane KJ, Abelson MB, Ousler III GW. Evaluation of Enhanced OPI; Using computerized video tracking of tear film break up for evaluation of tear film stability. Association for Research in Vision and Ophthalmology Meeting. 2010.
  29. Ousler III GW, Abelson MB, Welch DL. Enhanced precision of the Controlled Adverse Environment (CAE) system. Association for Research in Vision and Ophthalmology Meeting. 2010.
  30. Crawford KS, Gaines P, Breton SL, Chim HB, Lane KJ, Abelson MB. Comparative assessment of murine allergic conjunctivitis model variations for efficinet pre-clinical screening. Association for Research in Vision and Ophthalmology Meeting. 2010.
  31. White R, Rodriguez J, Lane KJ, Johnson P, Angjeli E, Abelson MB. Blink patterns in normal and dry eye subjects; Beyond blink rate. Association for Research in Vision and Ophthalmology Meeting. 2010.
  32. Breton S, Lane KJ, Gomes PJ, Shapiro A, Ousler III GW, Welch D, Abelson MB. Development of a redness scale for morning eye congestion. Association for Research in Vision and Ophthalmology Meeting. 2010.
  33. Hsu H-C, Patane M, Ousler III GW, Kennedy K, Johnston P, Abelson R. Leveraging phase II study data to effectively select primary endpoints and sample size for a phase III study. Association for Research in Vision and Ophthalmology Meeting. 2010.
  34. Gow JA, Williams JI, Gomes PJ, Abelson MB, McNamara TR. Rhinorrhea reduction using bepreve ophthalmic solution 1.5% in a clinical model of allergic conjunctivitis: An analysis of pooled data from two phase 3 conjunctival allergen challene (CAC) clinical trials. Association for Research in Vision and Ophthalmology Meeting. 2010.
  35. Rodriguez J, Angejeli E, Lane KJ, White R, Breton S, Abelson MB. Correlation between bllink rate, tear film corneal protection, and corneal staining. Association for Research in Vision and Ophthalmology Meeting. 2010.
  36. Abelson MB, Lane KJ, Maffei C. Code red: The key features of hyperemia. Review of Ophthalmology. 2010; 17(4):92-4.
  37. Abelson MB, Abelson R, Dewey-Mattia D. Clinical confounders. Review of Cornea and Contact Lens. 2010; 12.
  38. Abelson MB, Gomes P, Chaturvedi R. Production of an acute and late--phase response in allergic rhinitis in ian Allergen BioCube. American Academy of Allergy, Asthma & Immunology Meeting. 2010.
  39. McNamara TR, Williams JI, Gow JA, Gomes PJ, Abelson MB. . Bepreve 1.5% reduces rhinorrhea for at least 16 hours: An integrated analysis of two phase 3 Conjunctival Alelrgen Challenge (CAC) clinical trials. American Academy of Allergy, Asthma & Immunology Meeting. 2010.
  40. Abelson MB, Shapiro A. The many faces of adenovirus. Review of Ophthalmology. 2010; 17(3):66-9.
  41. Abelson MB, Lane KJ, Maffei CJ. Examining the red eye. Review of Cornea and Contact Lens. 2010; 14-15.
  42. Gomes P, Abelson MB, Mandell K. Perennial allergen skin sensitivity as a predictor of seasonal allergic rhinoconjunctivitis severity. American Academy of Allergy, Asthma & Immunology Meeting. 2010.
  43. Gow JA, Williams JI, McNamara TR, Gomes PJ, Abelson MB. Bepreve 1.5% reduces nasal congestion for at least 16 hours: an analysis of integrated data from two phase 3 Conjunctival Allergen Challenge (CAC) clinical trials. American Academy of Allergy, Asthma & Immunology Meeting. 2010.
  44. Abelson MB, Howe AJ, Maffei C, Shapiro A. A Fresh Perspective on Meibomitis. Review of Ophthalmology. 2010; 17(2):74-77.
  45. Abelson MB, Maffei C, Howe AJ. Why Doesn't the Ocular Drug Work?. Review of Ophthalmology. 2009; 16(12):42-44, 65.
  46. Abelson MB, Dewey-Mattia D, Maffei C, Ousler G, Shapiro A. New Treatments may improve dry eye care. Optometry Times. 2009; 14-15.
  47. Abelson MB, Mandell KJ, Howe A. When Tight Junctions Aren't Tight Enough. Review of Ophthalmology. 2009; 16(11):68-70.
  48. Abelson MB, Dewey-Mattia D. Recognizing Iritis. Review of Cornea and Contact Lens. 2009.
  49. Abelson MB, Mandell KJ, Shapiro A, Howe AJ. Should You Administer The Herpes Vaccine?. Review of Ophthalmology. 2009; 16(10):100-103.
  50. Abelson MB. Remembering Dr. Jeffrey Gilbard. Review of Ophthalmology. 2009; 16(10):104.
  51. Abelson MB, Tzekov R, Sena D, Lou P, Dewey-Mattia D. Address diabetic retinopathy by treating underlying disease. Ophthalmology Times. 2009; 28-32.
  52. Abelson MB, Tzekov R, Lou P, Sena D, Dewey-Mattia D. Emerging technology aids diabetic ritinopathy screening. Ophthalmology Times. 2009.
  53. Abelson MB, Ousler GW, Maffei C. Dry eye: through the years in tears. Review of Ophthalmology. 2009; 16(9):72-74.
  54. Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Clin Ther. 2009 Sep; 31(9):1908-21. PMID: 19843481.
    View in: PubMed
  55. Abelson MB, Howe AJ. MEMS and lenses. Review of Cornea and Contact Lens. 2009.
  56. Abelson MB, Tzekov RT, Howe AJ. Gene therapy turns foes into friends. Review of Ophthalmology. 2009; 16(8):56-58.
  57. Abelson MB, Ousler GW, Maffei C. Dry eye in 2008. Curr Opin Ophthalmol. 2009 Jul; 20(4):282-6. PMID: 19398910.
    View in: PubMed
  58. Abelson MB. ARVO brandishes the cutting edge. Review of Ophthalmology. 2009; 16(7):44-48.
  59. Tzekov RT, Abelson MB, Dewey-Mattia D. New Advances in Back of the Eye Drug Delivery. Retina Today. 2009; 1-5.
  60. Abelson MB, Dewey-Mattia D. Finding New Uses for Ancient Drugs. Review of Ophthalmology. 2009; 16(6):64-67.
  61. Abelson MB. Allergy control. Review of Cornea and Contact Lens. 2009.
  62. Abelson MB, Ousler III GW, Maffei C. Dry eye in 2008. Current Opinion in Ophthalmology. 2009; 20:282-6.
  63. Gow JA, Torkildsen GL, Williams JI, Gomes PJ, Abelson MB, McNamara TR. Bepotastine besilate ophthalmic solution 1.05 rapidly reduces conjunctival hyperemia in the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2009.
  64. Kurata FK, Macejko TT, Meier EJ, Bergmann MT, McLaurin EB, Williams JI, gow, JA, Abelson MB, McNamara TR. Bepotastine besilate ophthalmic solution 1.5% reduces tearing at 8 hours following dosing in a multi-site cllinical trial using the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2009.
  65. Abelson MB, Tzekov RT, Ousler GW, Shapiro A, Howe AJ, Maffei CJ. Pharmaceutical pipeline trying to address underserved areas of ophthalmology. Ophthalmology Times. 2009; 1:16-18.
  66. Abelson MB, Ousler G, Welch D, Nentwig B. Symptomatic break-up time (SBUT) in dry eye patients with normal vs. low corneal sensitivity. Association for Research in Vision and Ophthalmology Meeting. 2009.
  67. Macejko TT, McLaurin EB, Kurata FK, Meler EJ, Bergmann MT, Torkildsen GL, Gow JA, Abelson MB, McNamara TR. Bepotastine besilate ophthalmic solution 1.5% reduces ocular itching following dosing in the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2009.
  68. Gomes P, Abelson MB. Bepotastine besilate ophthalmic solution 1.0% rapidly reduces conjunctival hyperemia in the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2009.
  69. Protzko EE, Williams JI, Gow JA, Gomes PJ, Abelson MB, McNamara TR. The safety of the anti-histamine bepotastine besilate ophthalmic solution in a healthy pediatric population from ten to seventeen years of age. Association for Research in Vision and Ophthalmology Meeting. 2009.
  70. Abelson MB, Howe AJ, Gomes PJ, Guhlati A. More than "just an annoyance.". Review of Cornea and Contact Lens. 2009.
  71. Abelson MB, Lilyestrom LJ. Iodine: An Elemental Force Against Infection. Review of Ophthalmology. 2009; 16(5):80-3.
  72. Ousler G, Canova M, Nentwig B, Welch D, Abelson MB. Modification of tear film break-up pattern (TFBUP) in the Controlled Adverse Environment (CAE) model. Association for Research in Vision and Ophthalmology Meeting. 2009.
  73. Plumer A, Rosenthal A, Gulati A, Gomes P, Welch D, Abelson MB. Evaluation of daily ocular and nasal allergic signs and symptoms during 4 weeks of ragweed season in untreated allergic conjunctivits and rhinitis subjects. Association for Research in Vision and Ophthalmology Meeting. 2009.
  74. Curwen S, Ousler G, Nentwig B, Welch D, Abelson MB. Effect of Lacrisert(R) on the signs and symptoms of dry eye in contact lens wearers. Association for Research in Vision and Ophthalmology Meeting. 2009.
  75. Ousler G, Welch D, Abelson MB. Evaluation of functional visual performance using the IVAD method with currently marketed artificial tear products. Association for Research in Vision and Ophthalmology Meeting. 2009.
  76. Bergmann MT, Gomes PJ, Williams JI, Gow JA, Abelson MB, McNamara TR. Bepotastine besilate ophthalmic solution 1.5% reduces ocular itching in a multi-site clinical model of allergic conjunctivitis. American Society of Cataract and Refractive Surgery Meeting. 2009.
  77. Williams JI, Torkildsen GL, Gomes PJ, Gow JA, Abelson MB, McNamara TR. Effect of bepotastine besilate ophthalmic solution (1.0% and 1.5%) on eyelid swelling in a clinical model of allergic conjunctivitis. American Society of Cataract and Refractive Surgery Meeting. 2009.
  78. McNamara TR, Comes PJ, Abelson MB, Williams JI, Gow JA, Torkildsen GL. Effectiveness of bepotastine besilate ophthalmic solution 1.5% in reducing ocular itching in al allergic conjunctivitis model. American Society of Cataract and Refractive Surgery Meeting. 2009.
  79. Abelson MB, HOwe AJ, Lane KJ, Gomes PJ. An Eye-Opening Look at "Morning Eye.". Review of Ophthalmology. 2009; 16(4):86-88.
  80. Abelson MB, Howe AJ. A Clinical Profile of VKC. Review of Cornea and Contact Lens. 2009.
  81. Abelson MB, Howe AJ. A Clinical Profile of VKC. Review of Cornea and Contact Lens. 2009.
  82. Abelson MB, Dewey-Mattia D. Sjogren's Syndrome and Dry Eye, Part Two. Review of Cornea and Contact Lens. 2009.
  83. Abelson MB, Howe AJ. Serendipitous Drug Development. Review of Ophthalmology. 2009; 16(3):54-57.
  84. Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD. Vigabatrin: 2008 update. Epilepsia. 2009 Feb; 50(2):163-73. PMID: 19230067.
    View in: PubMed
  85. Abelson MB, Dewey-Mattia D, Crawford K. The Secret World of Pharmacokinetics. Review of Ophthalmology. 2009; 16(2):58-61.
  86. Abelson MB, Dewey-Mattia D. Sjogren's Syndrome and Dry Eye, Part One. Review of Cornea and Contact Lens. 2009.
  87. William JI, Gow, JA, Torkildsen GL, Gomes PJ, Abelson MB, McNamara TR. Bepotastine besilate ophthalmic solution reduces nasal symptoms in the Conjunctival Allergen Challenge (CAC) clinical model. Western Society of Allergy, Asthma, and Immunology Meeting. 2009.
  88. Abelson MB, Torkildsen GL, Williams JI, et al. Time to Onset and Duration of Action of the Antihistamine Bepotastine Besilate Ophthalmic Solutions 1.0% and 1.5% in Allergic Conjunctivitis: A Phase III, Single-Center, Prospective, Randomized, Double-Masked, Placebo-Controlled, Conjunctival Allergen Challenge Assesment in Adults and Children. Clinical Therapeutics. 2009.
  89. Walker PM, Lane KJ, Ousler GW III, Abelson MB. Diurnal variation of visual function and the signs and symptoms of dry eye. Cornea. 2009.
  90. Abelson MB. An Elastic Defense vs. Corneal Damage. Review of Ophthalmology. 2009; 16(1):64-67.
  91. Rosenwasser LJ, Mahr T, Abelson MB, Gomes PJ, Kennedy K. A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis. Allergy Asthma Proc. 2008 Nov-Dec; 29(6):644-53. PMID: 19063816.
    View in: PubMed
  92. Mahr T, Rosenwasser L, Abelson MB, Gomes PJ, Greiner JV. A comparison of olopatadine 0.2% ophthalmic solution (Pataday) versus fluticasone furoate nasal spray (Veramyst) for the treatment of allergic conjunctivitis. American College of Allergy, Asthma, and Immunology Annual Meeting. 2008.
  93. Tumaian E, Abelson MB, Gomes P, Kennedy K, Wall M. An evaluation of the efficy of olopatadine 0.2% (Pataday) in a modified conjunctival allergen challenge model. American College of Allergy, Asthma, and Immunology Annual Meeting. 2008.
  94. Chun DK, Shapiro A, Abelson MB. Ocular Pharmacokinetics. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:179-192.
  95. Abelson MB, Dewey-Mattia D, Shapiro A. Acanthamoeba: A Dangerous Pathogen. Review of Ophthalmology. 2008; 15(11):110-114.
  96. Abelson MB, Butrus S. Corticosteroids in Ophthalmic Practice. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:249-258.
  97. Abelson MB Howe AJ, Capriotti J, Shapiro A. Get To Know Your Antiseptic Options. Review of Ophthalmology. 2008; 15(12):64-67.
  98. Berdy GJ, Leonardi A, Abelson MB. Antihistamines and Mast Cell Stabilizers in Allergic Ocular Disease. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:265-280.
  99. Abelson MB, Torkildsen GL, Udell IJ. Allergic and Toxic Reactions: The Immune Response. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:611-624.
  100. To KW, Abelson MB, Neufeld AH. Nonsteroidal Anti-inflammatory Drugs. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:259-264.
  101. Abelson MB. Defining Dry Eye. Review of Cornea & Contact Lenses. 2008; (11):6.
  102. Abelson MB, Doane MG, Ousler G. Tear Film and Blink Dynamics. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:281-286.
  103. Abelson MB, Shapiro A, Maffei C. Questions remain regarding antibacterial therapy. Ophthalmology Times. 2008; (11).
  104. Torkildsen GL, Gomes PJ, Williams JI, Gow JA, Abelson MB, McNamara Tr. Evaluation of bepotastine besilate ophthalmic solution 1.0% in the conjunctival allergen challenge model of allergic conjunctivitis. American Academy of Ophthalmology Meeting. 2008.
  105. Abelson MB, Ousler G, Anderson R. Tear Substitutes. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2008; 1:287-292.
  106. Abelson MB, Lilyestrom L. The Whipsaw of Allergic Dry Eye. Review of Ophthalmology. 2008; 15(10):94-98.
  107. Abelson MB, Forte J, Shapiro A. MRSA: It's Not Just Resistant to Methicillin. Review of Ophthalmology. 2008; 15(9):82-85.
  108. Abelson MB, Gomes P, Lilyestrom L, Taylor A. When Allergic Conditions Collide. Review of Ophthalmology. 2008; 15(8):68-71.
  109. Rosenwasser LJ, Mahr T, Abelson MB, Gomes PJ, Kennedy K. A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis. Allergy Asthma Proceedings. 2008; 29:644-653.
  110. Abelson MB. Oral Treatment Options Abound for Dry Eye. Ophthalmology Times. 2008.
  111. Torkildsen GL, Abelson MB, Gomes PJ. Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: a single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis. Clin Ther. 2008 Jul; 30(7):1272-82. PMID: 18691986.
    View in: PubMed
  112. Abelson MB, Welch D. Innovation takes center stage at ARVO 2008 meeting. Ophthalmology Times. 2008; 33(15):16-17.
  113. Abelson, ORA Clinical R&D Staff. What We Leaned at ARVO 2008. Review of Ophthalmology. 2008; 15(7):74-78.
  114. Abelson MB, Shapiro A, Makino A, Lane K. The Other Side of Antibiotics. Review of Ophthalmology. 2008; 15(6):70-73.
  115. Abelson MB, Heller W, Shapiro AM, et al. Clinical cure of bacterial conjunctivitis with azithromycin 1%: Vehicle-controlled, double-masked clinical trial. American Journal of Ophthalmology. 2008; 146(6):959-65.
  116. Abelson MB, Lilyestron L. What Makes Up a Mast Cell?. Review of Cornea & Contact Lenses. 2008; (June):13.
  117. Ousler GW, Hagberg KW, Schindelar M, Welch D, Abelson MB. The Ocular Protection Index. Cornea. 2008 Jun; 27(5):509-13. PMID: 18520496.
    View in: PubMed
  118. Abelson MB, Lilyestron L. Irritating Infiltrates. Review of Cornea & Contact Lenses. 2008; (May):9.
  119. Abelson MB, Maffei C. What's Driving Patients Toward Homeopathy?. Review of Ophthalmology. 2008; 15(5):100-103.
  120. Lane KJ, Walker P, Ousler GW, White R, Abelson MB. The Effect of Increased Blink Rate on Visual Performance in Dry Eye Patients. Association for Research in Vision and Ophthalmology Meeting. 2008.
  121. Ousler GW, Power D, Schindelar M, Welch D, Abelson MB. A Phase II Double-Masked, Randomized, Parallel-Group Study to Assess the Safety and Efficacy of ALTY-0501 (Doxycycline 0.025% Ophthalmic Solution) in Dry Eye Patients Exposed to the Controlled Adverse Environment (CAE). Association for Research in Vision and Ophthalmology Meeting. 2008.
  122. Abelson MB, Edwards MR, Vogelson C, Pasquine T, Robertson SM. Effects of Olopatadine Hydrochloride Ophthalmic Solution, 0.2% (PatadayTM)on the Ocular Itching and Redness Associated With Allergic Conjunctivitis or Rhinoconjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2008.
  123. Schindelar MR, Prifogle E, Ousler GW, Maffei C, Abelson MB. Diurnal Variations in Symptoms of Dry Eye. Association for Research in Vision and Ophthalmology Meeting. 2008.
  124. Walker PM, Ousler GW, Lane K, White R, Welch D, Abelson MB. A Comparative Investigation of Spontaneous Blink Rates Across a Series of Tasks in Dry Eye and Control Patients. Association for Research in Vision and Ophthalmology Meeting. 2008.
  125. Abelson MB, Pfleger M, Casavant JS, Lilyestrom L, Leung S. Regulation of Registration. EyeWorld. 2008; (May).
  126. Abelson MB. Scientific Rigor Needed. Review of Cornea and Contact Lenses. 2008; (April).
  127. Abelson MB, Leung S. The Many Faces of Chlamydial Infection. Review of Ophthalmology. 2008; 15(4):84-87.
  128. Abelson MB, Gomes PJ. Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing. Expert Opin Drug Metab Toxicol. 2008 Apr; 4(4):453-61. PMID: 18433347.
    View in: PubMed
  129. Abelson MB, Heller W, Shapiro AM, Si E, Hsu P, Bowman LM. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. Am J Ophthalmol. 2008 Jun; 145(6):959-65. PMID: 18374301.
    View in: PubMed
  130. Abelson MB, Neufeld AH, Folkman J. The Rabbi-like Doctor. Retinal Physician. 2008.
  131. Abelson MB, Lilyestrom L. "Mad Eye Disease": Should You Worry?. Review of Ophthalmology. 2008; 15(3):94-98.
  132. Abelson MB, Gomes P, Leung S. Ocular Itching, Redness Key to Diagnosing Allergic Conjunctivitis. Primary Care Optometry News. 2008.
  133. Abelson MB, Leung S. The Yin and Yang of The Adenovirus. Review of Ophthalmology. 2008; 15(2):82-85, 105.
  134. Abelson MB. Does allergy article pass this challenge test? Letter to the Editor. Review of Ophthalmology. 2008; 15(2).
  135. Abelson MB, Leung S. Are You Probiotic?. Review of Cornea & Contact Lenses. 2008; (January/February):8.
  136. Abelson MB, Kennedy K, Lilyestrom L. Unraveling the Mystery of Endophthalmitis. Review of Ophthalmology. 2008; 15(1):60-63.
  137. Abelson MB, Spangler DL, Epstein AB, Mah FS, Crampton HJ. Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge. Curr Eye Res. 2007 Dec; 32(12):1017-22. PMID: 18085465.
    View in: PubMed
  138. Abelson MB, Sullivan DA, Ousler GW, Smith L, Maffei C. What You Missed at the TFOS Meeting. Review of Ophthalmology. 2007; 14(12):56-61.
  139. Abelson MB, Welch CL, Walker PM. Quality of Life with Dry Eye. Review of Cornea & Contact Lenses. 2007; 6.
  140. Abelson MB, Lilyestrom L. Melting Away the Myths of NSAIDs. Review of Ophthalmology. 2007; 14(11):124-128.
  141. Abelson MB, Ousler G, Lilyestrom L. Puffery Versus Scientific Integrity. Review of Cornea & Contact Lenses. 2007; (10):8.
  142. Abelson MB, Workman A, Taylor A. Eavesdropping on Blepharitis. Review of Ophthalmology. 2007; 14(10):92-96.
  143. Abelson MB, McLaughlin J. The Future of RPE Transplantation. Review of Ophthalmology. 2007; 14(9):72-75.
  144. Protzko E, Bowman L, Abelson M, Shapiro A. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Invest Ophthalmol Vis Sci. 2007 Aug; 48(8):3425-9. PMID: 17652708.
    View in: PubMed
  145. Abelson MB, Walker P. Breaking Down The Blink. Review of Ophthalmology. 2007; 14(8):68-71.
  146. Abelson MB, Gomes PJ, Pasquine T, Edwards MR, Gross RD, Robertson SM. Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis. Allergy Asthma Proceedings. 2007; 28(4):427-433.
  147. Abelson MB, Gomes PJ, Pasquine T, Edwards MR, Gross RD, Robertson SM. Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis. Allergy Asthma Proc. 2007 Jul-Aug; 28(4):427-33. PMID: 17883910.
    View in: PubMed
  148. Abelson MB, Welch D, McLaughlin J, Anderson R, Lilyestrom L, Taylor A. What We Learned at ARVO: 2007. Review of Ophthalmology. 2007; 14(7):70-74.
  149. Abelson MB, Plumer A. Target Allergens with the Body's Defenses. Review of Ophthalmology. 2007; 14(6):76-78, 92.
  150. Abelson M, Protzko E, Shapiro A, Garces-Soldana A, Bowman L. A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis. Clin Ophthalmol. 2007 Jun; 1(2):177-82. PMID: 19668507; PMCID: PMC2704516.
  151. Abelson MB, Walker PM. Allergy and Contact Lens Wear. Review of Cornea & Contact Lenses. 2007; 10.
  152. Walker P, Ousler GW, Workman DA, Hankin M, Abelson MB. Visual Function in Normals Compared to Patients Diagnozed With Dry Eye as Measured by the Inter-Blink Interval Visual Acuity Decay (IVAD) Test. Association for Research in Vision and Ophthalmology Meeting. 2007.
  153. Workman DA, Ousler GW, Abelson MB. Age Related Differences in Lid Margin Health. Association for Research in Vision and Ophthalmology Meeting. 2007.
  154. Cumberlidge G, Saragovi H, Lane KJ, Abelson MB. An Evaluation of D3, a Novel TrkA Receptor Agonist for Ability to Prevent Retinal Ganglion Cell Loss in a Rat Model of Glaucoma. Association for Research in Vision and Ophthalmology Meeting. 2007.
  155. Krokhmal L, Gomes P, Welch D, Abelson MB. The Incidence of Dry Eye With Topical Anti-Allergic Therapies. Association for Research in Vision and Ophthalmology Meeting. 2007.
  156. Crampton J, Abelson MB, Ousler GW, Pflugfelder S, De Paiva C, Forbes M, Power D. Correlation of the Controlled Adverse Environment (CAE) Model With a Murine Model of Experimental Dry Eye in Assessing the Ability of Topical Doxycycline to Prevent Corneal Barrier Disruption. Association for Research in Vision and Ophthalmology Meeting. 2007.
  157. Abelson MB, McLaughlin J. Allergy: The Search for Therapeutic Targets. Review of Ophthalmology. 2007; 14(5):106-108.
  158. Chaturvedi R, Gomes PJ, Welch D, Abelson MB. A Retrospective Analysis of the Predictive Value of Skin Tests Used in Subjects Screened in the Conjunctival Allergen Challenge Model. Association for Research in Vision and Ophthalmology Meeting. 2007.
  159. Ousler GW, Brazzell K, Durham T, Walker P, Anderson RT, Abelson MB. A Correlation Between Central Corneal Staining and Visual Function in Patients Diagnosed With Dry Eye. Association for Research in Vision and Ophthalmology Meeting. 2007.
  160. Abelson MB, Taylor A. Effect of Dosing Frequency on Patient Compliance. Review of Cornea & Contact Lenses. 2007; 8.
  161. Abelson MB, McLaughlin J. Inside the Cell: The Secrets of Steroids. Review of Ophthalmology. 2007; 14(4):122-124.
  162. Abelson MB, Lilyestrom L. Ocular Encounters of the Viral King. Review of Ophthalmology. 2007; 14(3):76-80.
  163. Abelson MB, Lilyestrom L. Drug-inducted Allergic Conjunctivitis. Review of Cornea & Contact Lenses. 2007; 8.
  164. Abelson MB, Lilyestrom. Paving the Pastures: Urban Life and Allergy. Review of Ophthalmology. 2007; 14(2):86-88.
  165. Abelson MB, Walker PM. A Colorful Future for Vision Testing. Review of Ophthalmology. 2007; 14(1):48-52.
  166. Abelson MB, Spangler DL, Epstein AB, Mah FS, Crampton HJ. Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge. Current Eye Research. 2007; 32:1017-1022.
  167. Abelson MB, Protzko E, Shapiro A, Graces-Soldana A, Gowman L. A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs. tobramycin in adult and pediatric subjects and bacterial conjunctivitis. Clinical Ophthalmology. 2007; 1(2):177-182.
  168. Abelson MB, Anderson R. SBUT and OPI Two Diagnostics to help us understand and stop the vicious cycle of dry eye. Review of Cornea & Contact Lenses. 2007; 8.
  169. Abelson MB, Walker P, Ousler GW, Plumer A. Dry Eye Diagnosis: It's All a Blur. Review of Ophthalmology. 2006; 13(12):50-52.
  170. Abelson MB, Anderson R. Demystifying Dumulcents. Review of Ophthalmology. 2006; 13(11):122-126.
  171. Abelson MB, Hartnett ME, McLaughlin J. Cutting-Edge Therapies for Wet AMD. Review of Ophthalmology. 2006; 13(10):100-102.
  172. Abelson MB, Ousler GW, Anderson R. Relieving Dry Eye Symptoms by Controling Common Environmental Factors. Refractive Eyecare. 2006; 10(11).
  173. Abelson MB, Mertz P, Ziyadeh N. The Hassles of Hypoxia. Review of Cornea & Contact Lenses. 2006; 8.
  174. Abelson MB, Ousler G, Anderson R. Simple Clinical Tips for Better Dry Eye Diagnoses. Ophthalmology Management. 2006.
  175. Abelson MB, Ousler G, Anderson R. Diagnostic Innovation for Dry Eye. EyeWorld. 2006.
  176. Abelson MB, Fink K. Fusarium Outbreak: Lessons Learned. Review of Ophthalmology. 2006; 13(9):88-90.
  177. Abelson MB, Anderson A. Tear Substitutes and Science. Review of Cornea & Contact Lenses. 2006; 42-45.
  178. Abelson MB, Mertz P. Pingueculitis. Review of Cornea & Contact Lenses. 2006; 7.
  179. Abelson MB, Oberoi S. Treating Dysfunctional Meibomian Glands. Review of Ophthalmology. 2006; 13(8):80-82.
  180. Abelson MB. Pearls from ARVO: Allergies, AMD, and therapeutics, among topics at this year's conference. EyeWorld. 2006; 11(8):22-26.
  181. Abelson MB, Guell J, Aguilar AJ, Bremond-Gignac D, Leonardi A, Liu Z, Merayo-Lloves J, McCluskey P, Seo KY, Zafirakis P. Treatment Options for Ocular Allergies: a global perspective. Proceedings of an Ocular Allergy Round Table Discussion. A Supplement to Ocular Surgery News, Europe/Asia-Pacific edition. 2006.
  182. Abelson MB, Lines L. The Ophthalmic Pharmaceutical Pipeline Expands. Ophthalmology Times. 2006; 31(13):20-22.
  183. Abelson MB, Granet D. Ocular allergy in pediatric practice. Curr Allergy Asthma Rep. 2006 Jul; 6(4):306-11. PMID: 16822383.
    View in: PubMed
  184. Abelson MB, Colby K, Alfonso E. The Fuss with Fusarium. EyeWorld. 2006; 11(7):50-52.
  185. Abelson MB, ORA Clinical R&D. Hot Topics from the 2006 ARVO Meeting. Review of Ophthalmology. 2006; 13(7):94-98.
  186. Abelson MB. Why are allergies increasing?. EyeWorld. 2006; 11(6):15-18.
  187. Abelson MB, Makino A. Keratitis: A Gram-Negative Situation. Review of Cornea & Contact Lenses. 2006; 10.
  188. Abelson MB, Ousler G, Schindelar M. Tear film stabilization: tools & treatments. EyeWorld. 2006; 11(6):11-13.
  189. Abelson MB, Shapiro A, Lapsa I. Meeting the Challenge of Conjunctivitis. Review of Ophthalmology. 2006; 13(6):78-81.
  190. Abelson MB, Protzko EE, Shapiro AM, AzaSite Clinical Study Group. A Randomized Trial Assessing Microbial Eradication and Clinical Efficacy of 1.0% Azithromycin Ophthalmic Solution vs Tobramycin in Pediatric and Adult Subjects with Bacterial Conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2006.
  191. Lichtenstein SJ, Abelson MB. Pharmacology, clinical efficacy and safety of olopatadine hydrochloride. Expert Rev Clin Immunol. 2006 May; 2(3):341-51. PMID: 20476906.
    View in: PubMed
  192. Gomes P, Abelson MB, Torkildsen G. Systemic Anti-Allergy Treatments May Cause Ocular Dryness While Topical Treatments Do No. European Histamine Research Society 35th Annual Meeting. 2006.
  193. Gomes P, Lane K, Abelson MB, Weston-Davies W. Use of rEV131 for Prevention of Anterior Chamber Inflammation in an Animal Model. European Histamine Research Society 35th Annual Meeting. 2006.
  194. Torkildsen G, Abelson MB. Comparison of Topical and Systemic Anti-Allergy Treatments Relative to Ocular Dryness. Association for Research in Vision and Ophthalmology Meeting. 2006.
  195. Gomes PJ, Yunes S, Welch D, Abelson MB. Evaluation of the Effect of Multiple Doses of Pred Forte (Prednisolone Acetate 1%) i the Prevention of Conjunctival Allergen Challenge-Induced Ocular Allergic Signs and Symptoms. Association for Research in Vision and Ophthalmology Meeting. 2006.
  196. Abelson MB, Anerson R. Mucus: Unpleasant Topic No More. Review of Cornea & Contact Lenses. 2006; 7.
  197. Ousler GW, Kellerman D, Durham T, Brazzell K, Kennedy K, Abelson MB. An Association Between Central Corneal Staining and Dry Eye Symptomatology. Association for Research in Vision and Ophthalmology Meeting. 2006.
  198. Casavant JS, Ousler GW, Wilcox-Hagberg K, Schindelar MR, Abelson MB. Duration of Dry Eye Diagnosis and Tear Film Break Up Pattens (TFBUPs). Association for Research in Vision and Ophthalmology Meeting. 2006.
  199. Abelson MB, Langelier N. A Blueprint for Your Own Dry-Eye Clinic. Review of Ophthalmology. 2006; 13(5):110-113.
  200. Protzko EE, Abelson MB, Shapiro AM, AzaSite Clinical Study Group. A Randomized Trial Assessing the Safety and Tolerability of 1.0% Azithromycin Ophthalmic Solution vs Tobramycin i Pediatric and Adult Subjects with Bacterial Conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2006.
  201. Marsters E, Ousler GW, Schindelar MR, Abelson MB. A Correlation Between Tear Film Break-Up Patterns (TFBUP) and the Schirmer's Test. Association for Research in Vision and Ophthalmology Meeting. 2006.
  202. Makino A, Lane KJ, Chapin MJ, Abelson MB. A Pilot Evaluation to Identify Morning Eyelid Swellng Using a Three Dimensional Digital Scanner. Association for Research in Vision and Ophthalmology Meeting. 2006.
  203. Davis JA, Ousler GW, Langelier NA, Oberoi SL, Schindelar MR, Wilcox-Hagberg K, Abelson R, Abelson MB. Seasonal Changes in Dry Eye Sumptomatology. Association for Research in Vision and Ophthalmology Meeting. 2006.
  204. Welch D, David JA, Torkildsen G, Ousler GW, Abelson MB. The Effect of Olopatadine 0.1% on Tear Film Stability. Association for Research in Vision and Ophthalmology Meeting. 2006.
  205. Schindelar MR, Ousler GW, Oberoi SL, Abelson MB. Perturbation of the Meibomian Glands and the Effect on Tear Film Stability and Tear Film Break-Up Paterns (TFBUPs) in an Ashkenazi Jewish Population. Association for Research in Vision and Ophthalmology Meeting. 2006.
  206. Wilcox-Hagberg K, Ousler GW, Schindelar MR, Anderson R, Abelson MB. Effects of Reflex Tearing on Tear Film Break-Up Time (TFBUT) and ear Film Break-Up Patterns (TFBUP) in a Population of Ashkenazi Jewish Patients. Association for Research in Vision and Ophthalmology Meeting. 2006.
  207. Workman DA, Wilcox-HagbergK, Ousler GW, Torkildsen GL, Abelson MB. Diurnal Signs and Symptoms Associated with Dry Eye. Association for Research in Vision and Ophthalmology Meeting. 2006.
  208. Abelson MB, Lines L. Why Patients are Going Back to Nature. Review of Ophthalmology. 2006; 13(4):70-73.
  209. Abelson MB, Lines L. Preservatives in Eye Care. Review of Cornea & Contact Lenses. 2006; 7.
  210. Abelson MB. Identifying Ocular Allergy. Refractive Eyecare. 2006.
  211. Abelson MB, Gomes P. The latest news in ocular allergy. EyeWorld. 2006; 11(4):42-44.
  212. Abelson MB. The eye-nose connection to allergies: A look at how the eyes, nose, and sinuses may contrbute to your patients' allergy misery. EyeWorld. 2006; 11(4):56-57.
  213. Abelson MB, Torkildsen G, Prehogan J. Biofilm and Contact Lens Wear. Review of Cornea & Contact Lenses. 2006; 7.
  214. Abelson MB, Vashlishan A. The Truth about Tachyphylaxis. Review of Ophthalmology. 2006; 13(3):112-115.
  215. Abelson MB, Hom MM. Improved patient questionnaires ease allergy diagnosis, enable targeted therapy. Primary Care Optometry News. 2006.
  216. Abelson MB, Torkildsen G, Fink K. Taking Steps Toward Better Compliance. Review of Ophthalmology. 2006; 13(2):86-91.
  217. Abelson MB, Lines L. The Illusion of an Explanation. Review of Cornea & Contact Lenses. 2006; 7.
  218. Abelson MB, Lines L. Hormones in Dry Eye: A Delicate Balance. Review of Ophthalmology. 2006; 13(1):68-70.
  219. Abelson MB, Torkildsen G, Plumer A, Yunes S. Giant Papillary Conjunctivitis. Review of Cornea & Contact Lenses. 2005; 2005:7.
  220. Abelson MB, Ousler, G, Plumer A. Heighten Dry-Eye Situational Awareness. Review of Ophthalmology. 2005; 12(12):64-66.
  221. Abelson MB, Ingerman A. The Dye-namics of Dry-Eye Diagnosis. Review of Ophthalmology. 2005; 12(11):72-75.
  222. Berger W, Abelson MB, Gomes PJ, Beck M, Kimura S, Westbrook T, Storms W, Galant S. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol. 2005 Oct; 95(4):361-71. PMID: 16279567.
    View in: PubMed
  223. Torkildsen G, French S, Shapiro A, Abelson MB. Comparison of the effects of moxifloxacin (0.5%) and gatifloxacin (0.3%) ophthalmic solutions on corneal sensitivity. 24th Biennial Cornea Research Conference. 2005.
  224. Abelson MB, Torkildsen G, Sleeper A. Corneal Erosion. Review of Cornea & Contact Lenses. 2005; 7.
  225. Abelson MB, Rosner B, Plumer A, Lines L. Dry-Eye: How to Ask The Right Questions. Review of Ophthalmology. 2005; 12(10):126-128.
  226. Wagner RS, Abelson MB, Shapiro A, Torkildsen G. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol. 2005 Sep; 123(9):1282-3. PMID: 16157821.
    View in: PubMed
  227. Ousler GW, Wilcox-Hagberg K, Casavant JS, Schindelar MR, Welch DW, Abelson MB. Tear fil break-up patterns in a population of dry eye patients of Ashkenazi Jewish descent. 24th Biennial Cornea Research Conference. 2005.
  228. Abelson MB, Torkildsen G, Shapiro A. Thinking Outside The Eyedropper. Review of Ophthalmolgoy. 2005; 12(9):78-80.
  229. Abelson MB, Forbes M. Dk: Part II. Review of Cornea & Contact Lenses. 2005; 7.
  230. Abelson MB, Torkildsen G. Diagnosing and Treating Allergic Conjunctivitis. Touch Scientific Briefings. 2005.
  231. Abelson MB, Ousler GW, Plumer A. Therapeutic Topics: An In-Depth Look at Our "Two Corneas.". Review of Ophthalmology. 2005; 8(12):70-73.
  232. Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocul Surf. 2005 Jul; 3(3):143-54. PMID: 17131019.
    View in: PubMed
  233. Abelson MB, Prehogan J, Marsters E, Davis J. What We Learned at ARVO 2005. Review of Ophthalmology. 2005; 12(7):76-80.
  234. Casavant J, Ousler GW, Wilcox-Hagberg K, Welch D, Abelson MB. . A Correlation Between the Signs and Symptoms of Dry Eye and the Duration of Dry Eye Diagnosis. Association for Research in Vision and Ophthalmology Meeting. 2005.
  235. Ousler GW, Haque R, Weichselberger A, Yannoulis NC, Abelson MB. Comparison of Pimecrolimus 1%, 0.3% and 0.1% With Vehicle for the Treatment of Dry Eye in the Controlled Adverse Environment (CAE) Model. Association for Research in Vision and Ophthalmology Meeting. 2005.
  236. Pratt SG, Ousler GW, Schindelar M, Chapin MJ, Abelson MB. Evaluation of a Novel Dry Eye Oral Supplement for the Treatment of the Signs and Symptoms of Dry Eye in the Controlled Adverse Environment (CAE) Model. Association for Research in Vision and Ophthalmology Meeting. 2005.
  237. McDonald N, Gomes PJ, Abelson MB, Berger W, Beck M, Kimura S, Westbrook T, Storms W, Galant S. Quality of life in rhinoconjunctivitis sufferers and the effects of topical ocular therapy. Association for Research in Vision and Ophthalmology Meeting. 2005.
  238. Schindelar M, Ousler GW, Abelson MB. Effect of Tear Film Stability on Ocular Surface Damage in a Population of Dry Eye Patients. Association for Research in Vision and Ophthalmology Meeting. 2005.
  239. Abelson MB, Chapin M, Plumer A. Ophthalmic Drugs: What’s in the Pipeline. Ophthalmology Times. 2005; 16-18.
  240. Lane K, Abelson MB, Chapin MJ, Goodhue K, Weston-Davies W. Evaluation of a Novel Anti-Inflammatory (rEV-131) Using Argon Laser Irradiation of the Iris in the Pigmented Rabbit. Association for Research in Vision and Ophthalmology Meeting. 2005.
  241. Christensen MT, Meadows DL, Stein JM, Tudor MR, Stone RP, Abelson MB, Michaelson C. A Comparison of Performance Attributes Between a New Concept Artificial Tear and Systane® Lubricant Eye Drops. Association for Research in Vision and Ophthalmology Meeting. 2005.
  242. Abelson MB, Workman DA. Meibomian Glands: Part II. Review of Cornea & Contact Lenses. 2005; 7.
  243. Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Turner FD, Wells DT, Robertson SM. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis. Curr Med Res Opin. 2005 May; 21(5):683-91. PMID: 15969867.
    View in: PubMed
  244. Wilcox-Hagberg K, Oulser GW, Casavant J, Welch D, Abelson MB . Effect of Menopause on the Ocular Protection Index (OPI) in a Population of Dry Eye Patients of Ashkenazi Jewish Descent. Association for Research in Vision and Ophthalmology Meeting. 2005.
  245. Abelson MB, Workman DA. Meibomian Glands: Part I. Review of Cornea & Contact Lenses. 2005; 7.
  246. Abelson MB, Plumer A. Interdisciplinary Work: The Wave of the Future. Review of Ophthalmology. 2005; 12(4):102-104.
  247. Abelson MB, Wilcox PE, Plumer A. What’s New in Spectacles. Review of Cornea & Contact Lenses. 2005; 8.
  248. Abelson MB. Ophthalmic Research Associates’ Dry Eye Department. Dry Eye’s Meeting Of the Minds. Review of Ophthalmology. 2005; 12(2):78-81.
  249. Abelson MB, Sleeper A. Insights on Anti-inflammatories. Review of Ophthalmology. 2005; 12(6):80-84.
  250. Abelson MB, Fink K. What Makes a Patient Allergic?. Review of Ophthalmology. 2005; 12(3):74-76.
  251. Abelson MB, Plumer A. Working Together to Heal the Cornea. Review of Ophthalmology. 2005; 12(5):112-116.
  252. Abelson MB, Plumer A. Marginal Infiltrates: A Mysterious Malady. Review of Ophthalmology. 2005; 12(1):66-68.
  253. Abelson MB, Plumer A, Lines L. Clinical Trial Registration: Implications of New Publication Policies and Proposed Legislation. Ophthalmology Times. 2005.
  254. Abelson MB, Plumer A. The Two Corneas. Review of Cornea & Contact Lenses. 2005; 8.
  255. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 2005 Jan; 115(1):118-22. PMID: 15637556.
    View in: PubMed
  256. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. Pediatr Allergy Immunol. 2004 Dec; 15(6):551-7. PMID: 15610370.
    View in: PubMed
  257. Abelson MB, Greiner JV. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model. Curr Med Res Opin. 2004 Dec; 20(12):1953-8. PMID: 15701212.
    View in: PubMed
  258. Ousler GW, Wilcox KA, Gupta G, Abelson MB. An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. Ann Allergy Asthma Immunol. 2004 Nov; 93(5):460-4. PMID: 15562885.
    View in: PubMed
  259. Goldberg D, Panigrahi D, Barazi M, Abelson M, Butrus S. A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes. Cornea. 2004 Oct; 23(7):736-7. PMID: 15448505.
    View in: PubMed
  260. Abelson MB. A review of olopatadine for the treatment of ocular allergy. Expert Opin Pharmacother. 2004 Sep; 5(9):1979-94. PMID: 15330735.
    View in: PubMed
  261. Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, Wells DT, Bergamini MV, Robertson SM. Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study. Clin Ther. 2004 Aug; 26(8):1237-48. PMID: 15476905.
    View in: PubMed
  262. Bremond-Gignac D, Abelson, Lou P. New treatments on the near horizon for AMD, CNV. Ocular Surgery New. 2004; 4:50-51.
  263. Lipkin N, Ousler GW, Abelson MB. A Correlation of Tear Film Break-Up Time and Age in Patients of Ashkenazi Jewish Descent Diagnosed with Dry Eye. Association for Research in Vision and Ophthalmology Meeting. 2004.
  264. Pollard S, Ousler GW, Lipkin N, Abelson MB. Dry Eye Quality of Life Questionnaire (DEQLQ©) – Outcome in a Population of Normals and Patients Diagnosed with Dry Eye. Association for Research in Vision and Ophthalmology Meeting. 2004.
  265. Casavant J, Ousler GW, Abelson MB. Effect of an Adverse Environment on Blink Rate in a Population of Dry Eye patients. Association for Research in Vision and Ophthalmology Meeting. 2004.
  266. Chapin M, Abelson MB, Lane K, Gomes PJ. An Investigation of the Role of H3 Histamine Receptor Selective Antagonist Clobenpropit in the Compount 48/80 Model of Allergic Conjunctivitis in the Guinea Pig. Association for Research in Vision and Ophthalmology Meeting. 2004.
  267. Kellerman DJ, Ousler G, Abelson M, Welch D, Mayhew A, Durham T, LaVange L, Yerxa B. Placebo-Controlled Evaluation of Diquafosol in a Controlled Adverse Environment (CAE). Association for Research in Vision and Ophthalmology Meeting. 2004.
  268. Wilcox KA, Ousler GW, Abelson MB. Effect of Menopause on the Ocular Protection Index (OPI) in a Population of Dry Eye Patients. Association for Research in Vision and Ophthalmology Meeting. 2004.
  269. Ousler GW, Welch DL, Abelson MB. Effect of Menopause on Blink Rate in a Population of Dry Eye Patients When Exposed to a Controlled Averse Environment (CAE). Association for Research in Vision and Ophthalmology Meeting. 2004.
  270. Abelson MB, Metson R, Fink K. The Eye and the Nose: What’s the Connection?. Review of Ophthalmology. 2004; 11(8):74-77.
  271. Abelson MB, Forbes M. The Enigma of Endophthalmitis. Review of Ophthalmology. 2004; 11(10):126-128.
  272. Whitcup SM, Bradford R, Lue J, Schiffman RM, Abelson MB. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Clin Ther. 2004 Jan; 26(1):29-34. PMID: 14996515.
    View in: PubMed
  273. Abelson MB, Fink K. Ocular Trauma Never Takes a Holiday. Review of Ophthalmology. 2004; 11(12):54-56.
  274. Abelson MB, Cohane K, Fink K. Blepharitis: Hiding In Plain Sight. Review of Ophthalmology. 2004; 11(5):106-109.
  275. Abelson MB, Shapiro A. Be Protected if Research Goes Awry. Review of Ophthalmology. 2004; 11(3):88-90.
  276. Abelson MB, Plumer A. Bacterial Resistance: The Ubiquitous Menace. Review of Ophthalmology. 2004; 11(11):80-83.
  277. Abelson MB, Pietrantonio J, Mertz P. Handling Contact Lens Complications. Review of Ophthalmology. 2004; 11(9):82-84.
  278. Abelson MB, Smith L, Fink K . The Best Corneal Surface for LASIK. Review of Ophthalmology. 2004; 11(1):68-70.
  279. Vogelson CT, Abelson MB, Pasquine T, Stephens DM, Gamache DA, Gross RD, Robertson SM, Yanni JM. Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration. Allergy Asthma Proc. 2004 Jan-Feb; 25(1):69-75. PMID: 15055565.
    View in: PubMed
  280. Abelson MB, Slugg AP, Izen MA. The Keys to Protecting Privacy in Research. Review of Ophthalmology. 2004; 11(4):104-107.
  281. Abelson MB, Thomson M, Parver L. AMD: New Therapies, New Mechanisms. Review of Ophthalmology. 2004; 11(6):76-80.
  282. Abelson MB, Gomes P, Crampton HJ, Schiffman RM, Bradford RR, Whitcup SM. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis. Clin Ther. 2004 Jan; 26(1):35-47. PMID: 14996516.
    View in: PubMed
  283. Abelson MB, Wilcox K, Fink K. New Insights on Allergy and Dry Eye. Review of Ophthalmology. 2004; 11(7):76-79.
  284. Abelson MB, Rosner S. Dry Eye: How to Study the Studies. Review of Ophthalmology. 2004; 11(2):66-68.
  285. Greiner JV, Mundorf T, Dubiner H, Lonsdale J, Casey R, Parver L, Kapik BM, Shams NB, Abelson MB. Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. Am J Ophthalmol. 2003 Dec; 136(6):1097-105. PMID: 14644221.
    View in: PubMed
  286. Mundorf T, Wilcox KA, Ousler GW, Welch D, Abelson MB. Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes. Adv Ther. 2003 Nov-Dec; 20(6):329-36. PMID: 15058750.
    View in: PubMed
  287. Leonardi A, Abelson MB. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans. Clin Ther. 2003 Oct; 25(10):2539-52. PMID: 14667955.
    View in: PubMed
  288. Spangler DL, Abelson MB, Ober A, Gotnes PJ. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther. 2003 Aug; 25(8):2245-67. PMID: 14512132.
    View in: PubMed
  289. Abelson MB, Pratt S, Mussoline JE, Townsend D. One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with contralateral use of olopatadine and artificial tears. Clin Ther. 2003 Jul; 25(7):2070-84. PMID: 12946551.
    View in: PubMed
  290. Abelson MB, Loeffler O. Conjunctival allergen challenge: models in the investigation of ocular allergy. Curr Allergy Asthma Rep. 2003 Jul; 3(4):363-8. PMID: 12791217.
    View in: PubMed
  291. Abelson MB, Smith L, Chapin M. Ocular allergic disease: mechanisms, disease sub-types, treatment. Ocul Surf. 2003 Jul; 1(3):127-49. PMID: 17075644.
    View in: PubMed
  292. Tinios L, Mroz M, Gomes PJ, Abelson MB. Flow Cytometric Analysis of ICAM-1 and HLA-DR Expression in Conjunctival Epithelium Following Allergen Challenge. Association for Research in Vision and Ophthalmology Meeting. 2003.
  293. Mroz M, Abelson MB. Ocular Surface Changes Associated with the use of Bimatoprost 0.03%. Association for Research in Vision and Ophthalmology Meeting. 2003.
  294. Wilcox KA, Mroz M, Lipkin N, Fillipon RL, Ousler GW, Abelson MB. Impact of Dry Eye on Daily Activities. Association for Research in Vision and Ophthalmology Meeting. 2003.
  295. Abelson MB, Gomes PJ, Welch DL, Pasquine TA Turner FD, Bergamini MVW, Robertson SM. Olopatadine reduces ocular signs and symptoms associated with allergic conjunctivitis 16 hours after instillation. Association for Research in Vision and Ophthalmology Meeting. 2003.
  296. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model. Arch Ophthalmol. 2003 May; 121(5):626-30. PMID: 12742839.
    View in: PubMed
  297. Abelson MB, Turner D. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis. Clin Ther. 2003 Mar; 25(3):931-47. PMID: 12852709.
    View in: PubMed
  298. Leonardi A, Murat M, Abelson M. Dual-action therapy important for complete allergy control. Ocular Surgery News. 2003.
  299. Abelson MB, Humphrey K, Dartt D. Mucin: What You Don’t Know May Help You. Vision Times - Translated into Japanese. 2003; 10(4):11-13.
  300. Abelson MB, Fink K. Controlling for The Placebo Effect. Review of Ophthalmology. 2003; 10(4):100-101.
  301. Abelson MB, Fink K. Ocular Allergy: From Basic Science to Clinic. Review of Ophthalmology. 2003; 10(5):53-58.
  302. Abelson MB, Shapiro A. Hitting the Bull’s-eye With Drug Delivery. Review of Ophthalmology. 2003; 10(7):82-84.
  303. Abelson MB, Mroz M, Rosner SA, Dirks MS, Hirabayashi D. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension. Adv Ther. 2003 Jan-Feb; 20(1):1-13. PMID: 12772813.
    View in: PubMed
  304. Abelson MB, Hallas SJ. How to Maximize Culture Effectiveness. Vision Times - Translated into Japanese. 2003; 10(2):1-3.
  305. Abelson, MB, MacDonald N, Humphrey K. New Insights from The ARVO Meeting. Review of Ophthalmology. 2003; 10(8):76-80.
  306. Abelson MB, Chapin MJ. Tracking the Ophthalmic Pharmaceutical Market. Review of Ophthalmology. 2003; 10(4):41-43.
  307. Abelson MB, Casavant J. Give Dry Eye A One-two Punch. Review of Ophthalmology. 2003; 10(3):74-77.
  308. Abelson MB, Schindelar M . Cheaper Lenses May Have a Hidden Cost. Review of Ophthalmology. 2003; 10(12):54-56.
  309. Abelson MB, Ousler GW, Humphrey K. Help Your Patients Understand Dry Eye. Review of Ophthalmology. 2003; 10(2):78-80.
  310. Abelson MB, Zieske J, MacDonal N. Taking Control of Corneal Healing. Review of Ophthalmology. 2003; 10(5):122-124.
  311. Abelson MB, Foster S, Gupta G . Diagnosis and Managing Anterior Uveitis. Vision Times - Translated into Japanese. 2003; 10(1):13-16.
  312. Abelson MB, Fink K. Allergy: How to Treat Lid Swelling. Vision Times - Translated into Japanese. 2003; 10(2):13-16.
  313. Abelson MB. Guest Editorial: Threats to the Role of Learned Intermediary. Review of Ophthalmology. 2003; 10(12).
  314. Abelson MB, Hallas SJ . The New Antibiotics: The Path of Least Resistance. Review of Ophthalmology. 2003; 10(4):47-49.
  315. Abelson MB, Rosner SA, MacDonald N. How to Be Comfortable With Painkillers. Review of Ophthalmology. 2003; 10(9):80-82.
  316. Abelson MB, Kumar R, Sleeper A. All You Need to Make an Artificial Tear. Review of Ophthalmology. 2003; 10(10):80-83.
  317. Abelson MB, Rosner SA. Prevent Drugs From Going Missing in Action. Review of Ophthalmology. 2003; 10(6):96-98.
  318. Abelson MB, Cohane K, D’Arienzo P. The Many Faces of Viral Conjunctivitis. Review of Ophthalmology. 2003; 10(11):126-128.
  319. Abelson MB. When Borders Affect Care, Patients Lose. Review of Ophthalmology. 2003; 10(12).
  320. Abelson MB, Humphrey K, Dartt D. Mucin: What You Don’t Know May Help You. Review of Ophthalmology. 2003; 10(1):70-73.
  321. Abelson MB. The American perspective – clinical experience of a new treatment. 2002.
  322. Abelson MB, Berdy GJ, Mundorf T, Amdahl LD, Graves AL. Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies. J Ocul Pharmacol Ther. 2002 Oct; 18(5):475-88. PMID: 12419098.
    View in: PubMed
  323. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Adv Ther. 2002 Jul-Aug; 19(4):161-9. PMID: 12431041.
    View in: PubMed
  324. Lanier BQ, Abelson MB, Berger WE, Granet DB, D'Arienzo PA, Spangler DL, Kägi MK. Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge. Clin Ther. 2002 Jul; 24(7):1161-74. PMID: 12182260.
    View in: PubMed
  325. Ousler GW, Emory TB, Welch D, Abelson MB. Factors that influence the inter-blink interval (IBI) as measured by the ocular protection index (OPI). Association for Research in Vision and Ophthalmology Meeting. 2002.
  326. Chapin M, N Nichols L, Ono S, Nakamura T, Davies WW, Nuttall P, Abelson MB. Evaluation of EV131, a histamine binding protein in a murine model of allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2002.
  327. Gomes PJ, Welch DL, Abelson MB. Assessment of the time course of itching, redness, eyelid swelling, and chemosis as induced by the conjunctival allergen challenge model of acute allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2002.
  328. D’Arienzo PA, Hallas SJ, Gupta G, Shapiro AM, Abelson MB. A Comparative study of the relative comfort of ciprofloxacin versus trimethoprim/polymyxin versus gentamicin ophthalmic solutions in a normal pediatric population. Association for Research in Vision and Ophthalmology Meeting. 2002.
  329. Abelson MB, Shams NBK, Kapik BM. Ocular Tolerance and safety of ketotifen fumarate 0.025% ophthalmic solution compared with placebo. International Congress of Ophthalmology. 2002.
  330. Abelson MB, Kaplan AP. A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model. Clin Ther. 2002 Mar; 24(3):445-56. PMID: 11952027.
    View in: PubMed
  331. Abelson MB, Chapin MJ, Sandman ER. Ocular Allergy. Krouse JH, Chadwick SJ, Gordon BR, Derebery MJ, editors. Allergy and Immunology an Otolaryngic Approach. 2002; 291-312.
  332. Abelson MB. Cornea/External Disease. Vision Times - Translated into Japanese. 2002; 9(4):4-5.
  333. Abelson MB, Smith L. Infectious Disease and Drug Resistance. Review of Ophthalmology. 2002; 9(6):43-52.
  334. Abelson MB, Fillipon R, Ousler GW. A Different Animal: Post-LASIK Dry Eye. Review of Ophthalmology. 2002; 9(8):92-95.
  335. Abelson MB, Leonardi A, Smith L. The Mechanisms, Diagnosis and Treatment of Allergy. Review of Ophthalmology. 2002; 9(4):74-84.
  336. Abelson MB, Fink K. How to Handle BAK Talk. Review of Ophthalmology. 2002; 9(12):52-54.
  337. Emory TB, Ousler GW, Abelson MB. All in the Blink of an Eye. Review of Ophthalmology. 2002; 9(3):82-85.
  338. Abelson MB, Emory T, Colby K. Protopic: A New Ally Against Inflammation. Review of Ophthalmology. 2002; 9(4):104-107.
  339. Welch D, Ousler GW, Nally LA, Abelson MB, Wilcox KA. Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect. Adv Exp Med Biol. 2002; 506(Pt B):1051-5. PMID: 12614031.
    View in: PubMed
  340. Abelson MB, Ousler GW, Nally LA, Welch D, Krenzer K. Alternative reference values for tear film break up time in normal and dry eye populations. Adv Exp Med Biol. 2002; 506(Pt B):1121-5. PMID: 12614039.
    View in: PubMed
  341. Abelson MB, Fillipon R, Ousler GW. A Different Animal: Post-LASIK Dry Eye. Review of Ophthalmology. 2002; 9(8):92-95.
  342. Abelson MB, Nichols LAB. Diagnostic Clues: Papillae and Follicles. Review of Ophthalmology. 2002; 9(10):112-117.
  343. Abelson MB, Ousler GW, Nally LA, Emory TB. Dry eye syndromes: diagnosis, clinical trials and pharmaceutical treatment--'improving clinical trials'. Adv Exp Med Biol. 2002; 506(Pt B):1079-86. PMID: 12614034.
    View in: PubMed
  344. Ousler GW, Abelson MB, Nally LA, Welch D, Casavant JS. Evaluation of the time to "natural compensation" in normal and dry eye subject populations during exposure to a controlled adverse environment. Adv Exp Med Biol. 2002; 506(Pt B):1057-63. PMID: 12614032.
    View in: PubMed
  345. Abelson MB, Nally L, Nichols L, Chapin M. What We Learned at the ARVO Meeting. Review of Ophthalmology. 2002; 9(7):84-86.
  346. Abelson MB, Pick N. ARMD and the promise of AREDS. Review of Ophthalmology. 2002; 9(2):86-90.
  347. Abelson MB, Washburn S. The Downside of Tear Preservatives. Review of Ophthalmology. 2002; 9(5):102-106.
  348. Abelson MB, Hallas SJ . How to Maximize Culture Effectiveness. Review of Ophthalmology. 2002; 9(9):90-94.
  349. Abelson MB, Carpenter S. Do beta-blockers discriminate?. Review of Ophthalmology. 2002; 9(2):67-68.
  350. Abelson MB, Fink K. Allergy: How to Treat Lid Swelling. Review of Ophthalmology. 2002; 9(8):32-38.
  351. Abelson MB, Foster S, Gupta G. Diagnosing and Managing Anterior Uveitis. Review of Ophthalmology. 2002; 9(6):110-114.
  352. Abelson MB, Fink K. How to Ensure Informed Consent. Vision Times. 2002; 9(3):14-16.
  353. Abelson MB, Casavant J, Nally L. The Secret (agogue) Is Out. Review of Ophthalmology. 2002; 9(11):72-76.
  354. Abelson MB, Parver L, Fink K, Welch D. Biological terrorism: what ophthalmologists may see. Review of Ophthalmology. 2002; 9(1):52-59.
  355. Abelson MB, Fink K. How to ensure informed consent. Review of Ophthalmology. 2001; 8(11):102-104.
  356. Abelson MB, Netland PA, Chapin MJ. Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model. Adv Ther. 2001 Nov-Dec; 18(6):282-97. PMID: 11841198.
    View in: PubMed
  357. Abelson MB, Ousler GW, Welch D. An Index for Measuring Clinically Relevant Alterations in Tear Film Break-Up Time. Biennial Cornea Research Conference. 2001.
  358. Abelson MB. The Allergy Medication Dilemma. Optometric Management. 2001.
  359. Abelson MB, Macias M, Shulman DG, Alfonso EC, Melton R. Winning the Allergy Wars. Proceedings of The Association for Research in Vision and Ophthalmology Meeting. A Supplement to Opthalmology Management. 2001.
  360. Abelson MB. Diagnostic Challenges in Allergy Patients. Ophthalmology Management. 2001; Supplement:3-5.
  361. Abelson MB, Ousler G. An inside look at the NEI dry eye meeting. Review of Ophthalmology. 2001; 8(8):82-84.
  362. Abelson MB, Nichols L. Open your eyes to dilation regimens. Review of Ophthalmology. 2001; 8(6):100-103.
  363. Abelson MB, Mroz M, Carpenter S. Listening to the rhythms of glaucoma. Review of Ophthalmology. 2001; 8(5):126-127.
  364. Abelson MB, Chapin MJ, Leonardi A. AKC: current and future treatments. Review of Ophthalmology. 2001; 8(4):100-102.
  365. Abelson MB. Allergy Wars: The Battle for Your Patient’s Red Eyes. Ophthalmology Management. 2001.
  366. Abelson MB. The Importance of Treating Ocular Allergy. Refractive Eyecare for Ophthalmologists. 2001; 5-10.
  367. Abelson MB, Chapin MJ. Lumigan: A new approach to managing IOP. Review of Ophthalmology. 2001; 8(2):58-60.
  368. Abelson MB. Clinically Speaking. Sightings. 2001.
  369. Abelson MB. Update on Allergy Medications. Review of Ophthalmology. 2001; 8(3):78-82.
  370. Abelson MB, Gifford S, Chapin MJ. Pharmocokinetics: what you need to know. Review of Ophthalmology. 2001; 9(1):60-63.
  371. Abelson MB, Pollard S, Chapin MJ. Phases of reactions: keys to diagnosis. Review of Ophthalmology. 2001; 8(10):86-89.
  372. Abelson MB, D’Arenzo PA, Friedman FN, Granet DB, Lanier RQ, Spangler DL, Brunell PA. Infectious Diseases in Children: The Diagnosis and Management of Red Eye. Slack Incorporated. 2001.
  373. Reaves AT, Abelson MB, Mundorf TK, Lonsdale J, Casey R, Parver LM, Brown AL, Kapik BM, Patterson SE, Shams NBK. Two Randomized, Double-Masked, Placebo-Controlled Single-Dose Efficacy and Safety Studies of Ketotifen Fumarate 0.025%. Invest Ophthalmol Vis Sci. 2001; 42(Suppl):4886.
  374. Abelson MB, Casavant JS, Granet DB. Tackling pediatric conjunctivitis. Review of Ophthalmology. 2001; 8(1):70-72.
  375. Abelson MB, Chapin MJ. So you want to run a research site. Review of Ophthalmology. 2001; 8(9):68-71.
  376. Lockhart DL, Abelson MB, Chapin MJ, Shapiro AP. Efficacy and Safety of Ketorolac Monotherapy Versus Dual Therapy With Prednisolone in Decreasing Post-LASIK Ocular Discomfort, Tearing, Photosensitivity, and Inflammation. Invest Ophthalmol Vis Sci. 2001; 42(Suppl):2662.
  377. Abelson MB, Grant A. What to do when you see red. Review of Ophthalmology. 2001; 8(12):44-49.
  378. Abelson MB, Ousler GW III, Welch DL, Nally L. The latest word on dry eye. Review of Ophthalmology. 2001; 8(3):86-89.
  379. Abelson MB, Ousler GW. Instillation of Ophthalmic Agents After Tear Film Break-Up Time to Enhance Treatment Effect. Invest Ophthalmol Vis Sci. 2001; 42(Suppl):944.
  380. Abelson MB, Norsworthy T, Melamed J. Take charge of allergic rhinitis treatment. Review of Ophthalmology. 2001; 8(7):86-89.
  381. Abelson MB. Differential Diagnosis and Pathophysiology of Ocular Allergic Diseases. Contemporary Issues in the Management of Ocular Allergy. 2001.
  382. Capone RC, Pietrantonio JJ, Abelson MB . How to Use Bandage Contact Lenses. Vision Times. 2001; 8(3):14-16.
  383. Abelson MB, Capone RC, Pietrantonio JJ . How to use bandage contact lenses. Review of Ophthalmology. 2000; 7(12):60-62.
  384. Abelson MB, DeFrutos R, Chapin M. What you need to know about ouixin. Review of Ophthalmology. 2000; 7(11):94-98.
  385. Abelson MB, Lemp MA, McDonald M, Onofrey BE, Pflugfelder S, Sheppard JD, Slade SG. Loteprednol Edabonate in the Managemeent of Dry Eye Inflammation. A Supplement to Refractive Eyecare for Ophthalmologists. 2000.
  386. Abelson MB . Pharmaceuticals. Review of Ophthalmology. 2000; 7(11):57-59.
  387. Abelson MB, Udell IJ, Nally L. An update on blepharitis treatment. Review of Ophthalmology. 2000; 7(10):164-166.
  388. Abelson, MB, Cantor, LB, DuBiner, HB, Noecker, RJ, Severin, TD, Samuelson, TW, Simmons, ST. New Paradigm for the Clinical Management of Glaucoma. A Supplement to Ocular Surgery News. 2000.
  389. Abelson MB, Sullivan JM. How to get patients to take their medicine. Review of Ophthalmology. 2000; 7(9):82-86.
  390. Abelson MB, Welch DL, Lynch SM. Good clinical practices: the investigator’s responsibilities. Review of Ophthalmology. 2000; 7(8):86-91.
  391. Abelson MB, Jain A, Krenz KL, Sobell JM . How to diagnose lid lesions. Review of Ophthalmology. 2000; 7(7):96-97.
  392. Abelson MB, Chapin MJ. What’s ahead in the drug pipeline. Review of Ophthalmology. 2000; 7(6):90-94.
  393. Abelson MB, Chapin MJ. The ophthalmic drug pipeline. Review of Ophthalmology. 2000; 7(5):120-124.
  394. Abelson MB, Nally L, Ousler GW. Dry eye, today and tomorrow. Review of Ophthalmology. 2000; 7(4):132-134.
  395. Sandman ER, Abelson MB. What’s in that medication anyway?. Review of Ophthalmology. 2000; 7(3):86-88.
  396. Sandman ER, Abelson MB. Molecular biology and ophthalmology. Review of Ophthalmology. 2000; 7(2):78-80.
  397. Abelson MB, Chapin MJ. Current and Future Topical Treatments for Ocular Allergy. Comprehensive Ophthalmology Update. 2000; 1:303-320.
  398. Shapiro AM, Abelson MB. Treat the patient, not the bottom line. Review of Ophthalmology. 2000; 7(1):72-74.
  399. Abelson MB, Welch DL. An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model. Acta Ophthalmol Scand Suppl. 2000; (230):60-3. PMID: 11057354.
    View in: PubMed
  400. Abelson MB. Overview. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2000; 201-202.
  401. Abelson MB, Raizman MB, Berdy GJ, Bonini S, Friedlaender MH, Fujishima H, Trocme SD. Ocular Allergies: A Clinical View to Management. 2000.
  402. Abelson MB, Granet DB, Bensch GW, Udell IJ, Berger WE. Solving the Ocular Allergy Puzzle. A Supplement to Review of Ophthalmology. 2000.
  403. Nally L, Ousler GW, Abelson MB. Ocular discomfort and tear film break-up time in dry eye patients: a correlation. Invest Ophthalmol Vis Sci. 2000; 41(Suppl):1436.
  404. Secchi A, Leonardi A, Discepola M, Deschenes J, Abelson MB. An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Emadine Study Group. Acta Ophthalmol Scand Suppl. 2000; (230):48-51. PMID: 11057351.
    View in: PubMed
  405. Abelson MB, Udell IJ. Allergic and Toxic Reactions. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2000; 781-803.
  406. Abelson MB, Butrus S. Corticosteroids in Ophthalmic Practice. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2000; 258-267.
  407. Nevius JM, Welch DL, Sandman E, Abelson M. Efficacy evaluation of ADL 2-1294 (loperamide hydrochloride ophthalmic solution 0.025%) vs. placebo for short term pain management. Invest Ophthalmol Vis Sci. 2000; 41(Suppl):4917.
  408. Nelson JD, Abelson MB. Tear Substitutes. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2000; 325-330.
  409. Crampton HJ, Chin JR, Milovanovic J, Deschenes J, Abelson MB. Chemosis is a useful marker in evaluating the efficacy of anti-allergic compounds in the allergen challenge model. Invest Ophthalmol Vis Sci. 2000; 41(Suppl):4925.
  410. Ousler GW, Crampton HJ, Abelson MB. An evaluation of signs and symptoms associated with the caruncle and plica semi-lunaris after exposure to a controlled adverse environment. Invest Ophthalmol Vis Sci. 2000; 41(Suppl):4936.
  411. Chapin MJ, Gomes PJ, Nuttall P, Paesen G, Abelson MB. Evaluation of a histamine binding protein derived from tick saliva in the rabbit model of allergic conjunctivitis. Invest Ophthalmol Vis Sci. 2000; 41(Suppl):1916.
  412. Secchi A, Ciprandi G, Leonardi A, Deschenes J, Abelson MB. Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjunctivitis. Emadine Study Group. Acta Ophthalmol Scand Suppl. 2000; (230):42-7. PMID: 11057350.
    View in: PubMed
  413. Abelson MB. Allergic Diseases of the Eye. 2000.
  414. To KW, Abelson MB, Neufeld AH. Nonsteroidal Antiinflammatory Drugs. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2000; 300-305.
  415. Crampton HJ, Abelson MB, Sandman ER, Gomes PJ. Therapeutic advances in the 20th century. Review of Ophthalmology. 1999; 7(12):66-68.
  416. Abelson MB, Slugg AP. Corneal wound healing and its modulation. Review of Ophthalmology. 1999; 6(11):92-98.
  417. Abelson MB, Rosner SA. How to handle drug-induced allergic conjunctivitis. Review of Ophthalmology. 1999; 6(10):146-148.
  418. Parver LM, Abelson MB, Milovanovic J. A look at alternative treatments for CNV. Review of Ophthalmology. 1999; 6(9):118-127.
  419. Abelson MB, Gomes PJ. CMV retinitis in the post-HAART era. Review of Ophthalmology. 1999; 6(8):110-113.
  420. Abelson MB, Ousler GW. How to fight computer vision syndrome. Review of Ophthalmology. 1999; 6(7):114-116.
  421. Abelson MB, LeMaitre NC, Wun PJ. An update on herpes therapy. Review of Ophthalmology. 1999; 6(6):144-145.
  422. Abelson MB, Crampton HJ, LeMaitre NC, Chapin MJ. Beta-blockers: Have they had their day in the sun?. Review of Ophthalmology. 1999; 6(5):154-156.
  423. Abelson MB, Randolph G, Krenz KL. The ophthalmologist's role in sinusitis. Review of Ophthalmology. 1999; 6(4):196-199.
  424. Abelson MB, LeMaitre NC. How to diagnose hypersensitivity reactions. Review of Ophthalmology. 1999; 6(3):104-106.
  425. Abelson MB, Paradis A, Grant KK. How to prescribe for the smallest sufferers. Review of Ophthalmology. 1999; 6(2):101-103.
  426. Abelson MB, Lanier RQ. The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model. Acta Ophthalmol Scand Suppl. 1999; (228):53-6. PMID: 10337434.
    View in: PubMed
  427. Grant KK, Abelson MB, Schultz C, Deschenes J, Baines MB, Antecka E. Use of a Neutrophil Chemotaxis Assay to Assess Potential Immunological Activity of Various Contact Lens Types. Invest Ophthal Vis Sci. 1999; 40(Suppl):4784.
  428. Abelson MB. Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl. 1999; (228):38-42. PMID: 10337431.
    View in: PubMed
  429. Ousler GW, Gomes PJ, Crampton HJ, Abelson MB. The Effects of a Lubricant Eye Drop on the Signs and Symptoms of Computer Vision Syndrome (CVS) Exacerbated in a Controlled Adverse Environment. Invest Ophthal Vis Sci. 1999; 40(Suppl):2847.
  430. Chapin MJ, George MA, Abelson MB. Broadening choices for the treatment of allergic conjunctivitis. Today's Therapeutic Trends. 1999; 17(1):67-84.
  431. Abelson MB, Chapin M, Batoosingh A, Chen K, York J. A Retrospective Examination of Drug-Induced Allergy to Alphagan㤠and a Proposal for a New Reporting System. Invest Ophthal Vis Sci. 1999; 40(Suppl):2718.
  432. Abelson MB, Greiner JV, Chin TL. A Comparison of the Effects of Ketotifen Furmarate 0.05%, Dimethindene Maleate 0.05%, and Levocabastine Hydrochloride 0.05% in the Allergen Challenge Model of Allergic Conjunctivitis. Ophthalmic Practice. 1999; 17(4):192-199.
  433. Discepola M, Deschenes J, Abelson M. Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl. 1999; (228):43-6. PMID: 10337432.
    View in: PubMed
  434. Deschenes J, Discepola M, Abelson M. Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model. Acta Ophthalmol Scand Suppl. 1999; (228):47-52. PMID: 10337433.
    View in: PubMed
  435. Abelson MB, Seaman C. How to get the most out of a product insert. Review of Ophthalmology. 1999; 6(1):88-89.
  436. Danjo Y, Watanabe H, Tisdale AS, George M, Tsumura T, Abelson MB, Gipson IK. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci. 1998 Dec; 39(13):2602-9. PMID: 9856770.
    View in: PubMed
  437. Abelson MB, LeMaitre NC . What we know about vitamins. Review of Ophthalmology. 1998; 5(12):68-69.
  438. Abelson M, Howes J, George M. The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate. J Ocul Pharmacol Ther. 1998 Dec; 14(6):533-42. PMID: 9867336.
    View in: PubMed
  439. Abelson MB, Giovanoni A. Can vitamin A make a comeback?. Review of Ophthalmology. 1998; 5(11):152-154.
  440. Abelson MB, McGarr PJ. Update on bacterial conjunctivitis. Review of Ophthalmology. 1998; 5(10):112-114.
  441. Harooni M, Freilich JM, Abelson M, Refojo M. Efficacy of hyaluronidase in reducing increases in intraocular pressure related to the use of viscoelastic substances. Arch Ophthalmol. 1998 Sep; 116(9):1218-21. PMID: 9747683.
    View in: PubMed
  442. Abelson MB. Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma Immunol. 1998 Sep; 81(3):211-8. PMID: 9759796.
    View in: PubMed
  443. Abelson MB, Ousler GW. A tool for tuning anti-allergy drugs. Review of Ophthalmology. 1998; 5(9):132-134.
  444. Abelson MB, Chapin MJ, Heimigner JH. Compliance-friendly CAIs. Review of Ophthalmology. 1998; 5(8):112-113.
  445. Abelson MB, Connell C. Emadine: A new way to fight allergy. Review of Ophthalmology. 1998; 5(7):98-99.
  446. Abelson MB, Spitalny L. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol. 1998 Jun; 125(6):797-804. PMID: 9645717.
    View in: PubMed
  447. Abelson MB, Nevius JM. A kinder, gentler steroid?. Review of Ophthalmology. 1998; 5(6):104-105.
  448. Abelson MB, Connell C, Hartnett ME. A new way to fight retinal disease?. Review of Ophthalmology. 1998; 5(5):122-123.
  449. Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill D, Schaich L. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther. 1998 Apr; 14(2):137-45. PMID: 9572539.
    View in: PubMed
  450. Abelson MB, McGarr PJ. Understanding the drug approval process. Review of Ophthalmology. 1998; 5(4):154-156.
  451. Abelson MB, Schwartz E. How to battle seasonal allergy. Review of Ophthalmology. 1998; 5(3):118-122.
  452. Abelson MB, Grant KK. Should we allow generic substitutions?. Review of Ophthalmology. 1998; 5(2):95-99.
  453. Abelson MB, Reynolds O. Are You Missing These Common Eyelid Disorders?. Skin & Aging. 1998; 48-53.
  454. Grant K, Abelson MB, George MA, Connell C, Giovanoni A. Metaplastic Changes to the Led Margin Epithelium. Invest Ophthal Vis Sci. 1998; 39(Suppl):2472.
  455. Abelson MB, Howes J, George M. The conjunctival provocation test model of ocular allergy: Utility for assessment of an ocular corticosteroid, loteprednol etabonate. Journal of Ocular Pharm. 1998; 14:533-542.
  456. Donshik PC, Nelson JD, Abelson M, McCulley JP, Beasley C, Laibovitz RA. Effectiveness of BION tears, Cellufresh, Aquasite, and Refresh Plus for moderate to severe dry eye. Adv Exp Med Biol. 1998; 438:753-60. PMID: 9634964.
    View in: PubMed
  457. Abelson MB, Schwartz E, Chapin MJ. A guide to topical anesthetics. Review of Ophthalmology. 1998; 5(1):94-96.
  458. Harooni M, Freilich JM, Abelson M, Refojo M. Use of Hyaluronidase in Reducing visoelastic related Increases in Intraocular Pressure. Invest Ophthal Vis Sci. 1998; 39(Suppl):3258.
  459. McGarr PJ, Abelson MB, Chin T, Grant KK, George MA. A Retrospective Evaluation of the Effects of a Daily Disposable Wearing Schedule on Lens Comfort and Wearing Time in Patients with a History of Soft Contact Lens Wear Failure. Invest Ophthal Vis Sci. 1998; 39(Suppl):307.
  460. Abelson MB, Crampton HJ. What's new in dry eye treatment?. Review of Ophthalmology. 1997; 4(12):68-69.
  461. Abelson MB, Grant KK. NSAIDS: an alternative to steroids?. Review of Ophthalmology. 1997; 4(11):84-85.
  462. Abelson, MB, Crampton HJ. The promise of cyclosporin-A. Review of Ophthalmology. 1997; 4(10):203-204.
  463. Abelson MB, Chapin M. Making sense out of glaucoma medications. Review of Ophthalmology. 1997; 4(9):122-127.
  464. Abelson MB, Pyun J. Understanding mast-cell stabilizers. Review of Ophthalmology. 1997; 4(8):146-148.
  465. Abelson MB, Giovanoni A. How to specify artificial tears. Review of Ophthalmology. 1997; 4(7):108-109.
  466. Abelson MB, McGarr PJ. What we know about blepharitis. Review of Ophthalmology. 1997; 4(6):129-130.
  467. Abelson MB, Giovanoni A. The 3 myths of topical adrenergic agents. Review of Ophthalmology. 1997; 4(5):114-115.
  468. Abelson MB, McGarr, P. How to Understand and Treat Corneal Ulcers. Supplement to Review of Optometry. 1997; 10A-14A.
  469. Abelson MB, Schwartz E. A new way to treat allergic conjunctivitis. Review of Ophthalmology. 1997; 4(4):150-152.
  470. Abelson MB, McGarr P. How to diagnose and treat inclusion conjunctivitis. Review of Ophthalmology. 1997; 4(3):123-125.
  471. Abelson MB, Michaelson C, Grant KK. Managing migraines. Review of Ophthalmology. 1997; 4(2):121-123.
  472. McGarr PJ, Abelson MB, Gerolmatos B, Frisch S, Neibart S. Comparioson of the Topical Antihistamine/Decongestant Ocuhist vs the Oral Antihistamine Claritin. Invest Ophthal Vis Sci. 1997; 38(Suppl):5028.
  473. Abelson MB, Schwartz EM. The challenge of post operative pressure spikes. Review of Ophthalmology. 1997; 4(1):128-129.
  474. Casey R, Abelson MB. Atopic keratoconjunctivitis. Int Ophthalmol Clin. 1997; 37(2):111-7. PMID: 9269601.
    View in: PubMed
  475. Abelson MB, Grant KK. Unlocking the mystery of photophobia. Review of Ophthalmology. 1996; 3(12):68-69.
  476. Abelson MB, Grant KK. What we do and do not know about latanoprost. Review of Ophthalmology. 1996; 3(11):102-103.
  477. Abelson MB, Jordan T, Welch D. Brimonidine: a new alternative in glaucoma therapy. Review of Ophthalmology. 1996; 3(10):162-164.
  478. Abelson MB, Abelson S, Erikson K, George MA. Can we treat ischemic optic neuropathy. Review of Ophthalmology. 1996; 3(9):118-119.
  479. Abelson MB, Sloan J, Welch D. Taming the steroid. Review of Ophthalmology. 1996; 3(8):110-111.
  480. Abelson MB, MD, Pyun J. New advances in ophthalmic drug delivery. Review of Ophthalmology. 1996; 3(7):100-101.
  481. Abelson MB, Sloan J. How to manage corneal burns. Review of Ophthalmology. 1996; 3(6):122-123.
  482. Abelson MB, Casey R. How to manage atopic keratoconjunctivitis. Review of Ophthalmology. 1996; 3(5):146-147.
  483. Abelson MB, John T. How to manage epidemic keratoconjunctivitis. Review of Ophthalmology. 1996; 3(4):120-122.
  484. Abelson MB, Pyun J. Understanding NSAIDs. Review of Ophthalmology. 1996; 3(3):131-133.
  485. Abelson MB, Schaefer K, Alfonso E. How to manage fungal keratitis. Review of Ophthalmology. 1996; 3(2):128-129.
  486. Abelson MB, Schaefer K, Frisch SF, Gerolimatos B, Neibart SI. OcuHist is superior to Benadryl in inhibiting the signs and symptoms of allergic conjunctivitis. Invest Ophthal Vis Sci. 1996; 37(Suppl):2728.
  487. Pyun JC, Abelson MB, Richard KP, McMahon JK, Scannon PJ, Carroll SF. Evaluation of the antimicrobial and antiangiogenic properties of a novel recombinant protein. Invest Ophthal Vis Sci. 1996; 37(Suppl):224.
  488. Abelson MB, McGarr PJ, Richard KP. Anti-Allergic Therapies. Textbook of Ocular Pharmacology. 1996.
  489. Abelson MB, George MA. Confusion in the OTC marketplace. Review of Ophthalmology. 1996; 3(1).
  490. Lowry GM, Abelson MB, Rubin JM. Emedastine ophthalmic solution alleviates ocular itching and redness associated with allergic conjunctivitis. Invest Ophthal Vis Sci. 1996; 37(Suppl):2731.
  491. Richard KP, Abelson MB, George MA, Silor D, Schultz CL. Cytokine influence on the development of acute immune reactions. Invest Ophthal Vis Sci. 1996; 37(Suppl):222.
  492. Spitalny L, Abelson MB. Olopatadine ophthalmic solution decreases itching and redness associated with allergic conjunctivitis. Invest Ophthal Vis Sci. 1996; 37(Suppl):2730.
  493. Abelson MB, Leonardi AA, Smith LM, Fregona IA, George MA, Secchi AG. Histaminase activity in patients with vernal keratoconjunctivitis. Ophthalmology. 1995 Dec; 102(12):1958-63. PMID: 9098303.
    View in: PubMed
  494. Abelson MB, Richard K. How to handle herpes zoster ophthalmicus. Review of Ophthalmology. 1995; 2(12):58-59.
  495. Abelson MB, Giovanoni R, Schaefer K. How topical drugs work. Review of Ophthalmology. 1995; 2(11):88-89.
  496. Abelson MB, Pavan-Langston D, McGarr P. How to manage ocular herpes simplex infections. Review of Ophthalmology. 1995; 2(10):186-188.
  497. Abelson MB, McMahon J. How to diagnose and treat acanthamoeba keratitis. Review of Ophthalmology. 1995; 2(9):103-105.
  498. Abelson MB, Parver L, Pyun J. How to treat uveitis. Review of Ophthalmology. 1995; 2(8):107-109.
  499. Abelson MB, Sloan J. How to guard against in-office HIV transmission. Review of Ophthalmology. 1995; 2(7):58-59.
  500. Abelson MB, Sloan J. The early warning signs of HIV. Review of Ophthalmology. 1995; 2(6):104-106.
  501. Abelson MB, Zbyszynski B. How to manage recurrent corneal erosion. Review of Ophthalmology. 1995; 2(5):130-131.
  502. Abelson MB, Madiwale N. How to handle ocular hypertension. Review of Ophthalmology. 1995; 2(4):100-101.
  503. Abelson MB, George MA. How to care for acne rosacea. Review of Ophthalmology. 1995; 2(3):131-132.
  504. Abelson MB, George MA, Smith LM. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model. Ophthalmology. 1995 Feb; 102(2):310-6. PMID: 7862419.
    View in: PubMed
  505. Abelson MB, Schaefer K. The finer points of corneal abrasion management. Review of Ophthalmology. 1995; 2(2):111-112.
  506. Abelson MB, George MA, Schaefer KM, McGarr PJ. Identification of a refractory period of the human conjunctival mast cell. Invest Ophthal Vis Sci. 1995; 36(Suppl):4692.
  507. Ginsburg AP, Cheetham JK, DeGryse RE, Abelson M. Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: functional vision and contrast sensitivity. J Cataract Refract Surg. 1995 Jan; 21(1):82-92. PMID: 7722912.
    View in: PubMed
  508. Secchi A, Leonardi A, Abelson M. The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis. Ocul Immunol Inflamm. 1995; 3(1):23-8. PMID: 22827228.
    View in: PubMed
  509. Abelson, MB. Technical narrative on NeuprexTM (rBPI 21). Annual Report. 1995.
  510. Abelson MB, Richard K. The mystery of peripheral marginal infiltrates. Review of Ophthalmology. 1995; 2(1):84-85.
  511. Richard KP, Abelson MB, Schultz CL, Greiner JV, George MA. Occurrence of giant papillary conjunctivitis-like changes of the inferior tarsal conjunctiva described in a rabbit population. Invest Ophthal Vis Sci. 1995; 36(Suppl):4704.
  512. Schaefer K, Abelson MB, Richard KP, Schultz CL. Ulceration of New Zealand white rabbit corneas induced by intrastromal injection of IL-1. Invest Ophthal Vis Sci. 1995; 36(Suppl):4668.
  513. McGarr PJ, Abelson MB, Richard KP. Determination of tryptase levels in subjects following conjunctival provocation with allergen. Invest Ophthal Vis Sci. 1995; 36(Suppl):4700.
  514. Abelson MB, Welch D. How to treat bacterial conjunctivitis. Review of Ophthalmology. 1994; 1(9):44-45.
  515. Abelson MB, McGarr P. A better way to treat blepharospasm and strabismus. Review of Ophthalmology. 1994; 1(8):56-57.
  516. Abelson MB, Parver L. How to handle CME in pseudophakes. Review of Ophthalmology. 1994; 1(7):138-139.
  517. Abelson MB, George MA, Schaefer K, Smith LM. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis. J Allergy Clin Immunol. 1994 Sep; 94(3 Pt 1):458-64. PMID: 7916020.
    View in: PubMed
  518. Abelson MB, Zbyszynski B. How to diagnose and treat blepharitis. Review of Ophthalmology. 1994; 1(6):72-73.
  519. Abelson MB, Richard K. What we know and don't know about GPC. Review of Ophthalmology. 1994; 1(5):64-65.
  520. Abelson MB, Welch D. How and why to treat dry eye. Review of Ophthalmology. 1994; 1(4):58-59.
  521. Abelson MB, George MA. . Why use intra-operative miotics?. Review of Ophthalmology. 1994; 1(3):85-86.
  522. Abelson MB, Schaefer K . How to manage vernal keratoconjunctivitis. Review of Ophthalmology. 1994; 1(2):68-69.
  523. Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlaender M, McCulley JP. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol. 1994 Apr 15; 117(4):488-97. PMID: 8154531.
    View in: PubMed
  524. Abelson MB, Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur J Ophthalmol. 1994 Apr-Jun; 4(2):91-101. PMID: 7950341.
    View in: PubMed
  525. Abelson MB, Sloan J. Nonsteroidal anti-inflammatory drugs. Current ophthalmic therapy. J Fla Med Assoc. 1994 Apr; 81(4):261-3. PMID: 8046366.
    View in: PubMed
  526. Timoptic-XE Study Group. Timoptic-XE vs Timoptic Double-Masked Study. American Academy of Ophthalmology. 1994.
  527. Abelson MB. The Efficacy of Levocabastine in the Antigen Challenge Model. Proceedings of Levocabastine Investigator’s Symposium. 1994.
  528. Schaefer K, George MA, Abelson MB, Garofalo C. A scanning electron micrographic comparison of the effects of two preservative-free artificial tear solutions on the corneal epithelium as compared to a phosphate buffered saline and a 0.02% benzalkonium chloride control. Adv Exp Med Biol. 1994; 350:459-64. PMID: 8030519.
    View in: PubMed
  529. Abelson MB, Knight E. Dry eye therapy: evaluation of current directions and clinical trials. Adv Exp Med Biol. 1994; 350:431-6. PMID: 8030514.
    View in: PubMed
  530. Abelson MB . Overview. Albert DM, Jakoviec FA, editors. Principles and Practice of Ophthalmology. 1994; 915-916.
  531. Dell SJ, Rubin JM, Lowry GM, Campbell K, Springer V, Dobbs R, Abelson MB. Evaluation of Naphcon-A and individual constituents by provocative antigen challenge. Invest Ophthal Vis Sci. 1994; 35(Suppl):183.
  532. George MA, Abelson MB, Schaefer K, Mooshian M, Weintraub D. A precise method of using rose bengal in the evaluation of dry eye and the detection of changes in its severity. Adv Exp Med Biol. 1994; 350:549-52. PMID: 7518185.
    View in: PubMed
  533. Berdy GJ, Abelson MB. Antihistamines and Mast Cell Stabilizers in Allergic Ocular Disease. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 1994; 1028-1042.
  534. Tauber J, Abelson MB, Ostrov C, Laibovitz M, Raizman M, Betts J, Koester J, Gill D . A multicenter comparison of diclofenac sodium 0.1% (DS) to ketorolac tromethamine 0.5% (KT) in patients with acute seasonal allergic conjunctivitis. Invest Ophthal Vis Sci. 1994; 35(Suppl):180.
  535. To K, Abelson MB, Neufeld A. Nonsteroidal antiinflammatory drugs. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 1994; 1022-1027.
  536. Abelson MB, Wagoner MD, section editors. . Sclera. Albert DM, Jacobiec FA. Principles and Practice of Ophthalmology. 1994.
  537. Ueno N, Refojo MF, Abelson MB. Pharmacokinetics. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 1994; 916-928.
  538. Abelson MB. Tear Substitutes. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 1994; 1055-1060.
  539. George MA, Abelson MB, Schaefer K, Mooshian M, Weintraub D. A precise method of using rose bengal in the evaluation of dry eye and the detection of changes in its severity. Lacrimal Gland, Tear Film, and Dry Eye Syndromes. 1994; 350:549-552.
  540. Abelson MB, Butrus S. Corticosteroids in Ophthalmic Practice. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 1994; 1013-1022.
  541. Abelson MB, Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol. 1993 Jul-Aug; 38 Suppl:115-32. PMID: 7901917.
    View in: PubMed
  542. Poggio EC, Abelson MB. Complications and symptoms with disposable daily wear contact lenses and conventional soft daily wear contact lenses. CLAO J. 1993 Apr; 19(2):95-102. PMID: 8495566.
    View in: PubMed
  543. Abelson MB, George MA, Garofalo C. Differential diagnosis of ocular allergic disorders. Ann Allergy. 1993 Feb; 70(2):95-109. PMID: 8430929.
    View in: PubMed
  544. Abelson MB, Greiner JV, Chin TLN, Mooshian M. Adaptive changes in the threshold sensitivity of the tarsus as measured with cochet-bonnet aesthesiometer. Invest Ophthal Vis Sci. 1993; 34(Suppl):1006.
  545. Poggio EC, Abelson M. Complications and symptoms in disposable extended wear lenses compared with conventional soft daily wear and soft extended wear lenses. CLAO J. 1993 Jan; 19(1):31-9. PMID: 8453750.
    View in: PubMed
  546. Bowman LM, Abelson MB, Doane MG, Eto CY. An evaluation of the retention time of artificial tear treatments in dry eye patients using tear film interferometry. Invest Ophthal Vis Sci. 1993; 34(Suppl):1472.
  547. Shedden AH, Laurence JK, Tipping RW, Voge R, Abelson MB, Allen RC, Brown RH, Cacioppo LR, Greenberg M, Greenidge KC, Haik BG, Koby MM, Karp DW, Levy NS, Rice R, Shrader E, Vela-Thomas MA, Weiss MJ. Youens HT, Zimmerman TJ. Multiclinic, double-masked study of 0.5% timoptic-XE (TXE) once daily versus 0.5% timoptic(TS) twice daily. Ophthalmology. 1993; 100(Suppl):111.
  548. Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects. Arch Ophthalmol. 1992 Apr; 110(4):528-32. PMID: 1562263.
    View in: PubMed
  549. Ormerod LD, Garsd A, Abelson MB, Kenyon KR. Eicosanoid modulation and epithelial wound healing kinetics of the alkali-burned cornea. J Ocul Pharmacol. 1992; 8(1):53-8. PMID: 1328428.
    View in: PubMed
  550. Abelson MB, George MA, Drake M, Von Tress M, Miller B. Evaluation of rimexolone ophthalmic suspension in the antigen challenge model of allergic conjunctivitis. Invest Ophthal Vis Sci. 1992; 33(Suppl):1112.
  551. Abelson MB. Ocular Allergy. Ophthalmology McGill. 1992; 4(2):11.
  552. Smith LM, Abelson MB, George MA, West L. A double-masked study on the effects ofophthalmic levocabastine vs. placebo on the signs and symptoms of allergic conjunctivitis. Invest Ophthal Vis Sci. 1992; 33(Suppl):1297.
  553. Butrus SI, Laby DM, Zacharia JS, Abelson MB, Craig SS, Schwartz LB. Ultrastructural analysis of conjunctival mast cells in giant papillary conjunctivitis. Invest Ophthal Vis Sci. 1992; 33(Suppl):851.
  554. Laby DM, Butrus SI, Tabbara SO, Hidayat AA, Abelson MB. Increased number of mast cells in pterygium. Invest Ophthal Vis Sci. 1992; 33(Suppl):984.
  555. George MA, Smith LM, Abelson MB. Comparison of an H1/H2 receptor antagonist combination compared with the individual components evaluated in an antigen challenge model. Invest Ophthal Vis Sci. 1992; 33(Suppl):851.
  556. Abelson MB, Smith LM, George MA, Thayer TO. The efficacy of a new anti-allergic agent, Pentyde®, in the allergen challenge model of allergic conjunctivitis. Invest Ophthalmol Visual Sci. 1991; 32(Suppl):683.
  557. Berdy GJ, Abelson MB, George MA, Smith LM, Giovanoni RL. Allergic conjunctivitis: a survey of new antihistamines. J Ocul Pharmacol. 1991; 7(4):313-24. PMID: 1687324.
    View in: PubMed
  558. Abelson MB, Smith LM. Mediators of Ocular Inflammation. Tasman W, editor. Duane's Foundations of Clinical Ophthalmology. 1991; 1-10.
  559. Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tears and the cornea. Archives of Ophthalmol. 1991.
  560. Friedlaender MH, Haghihi B, Stein PC, Abelson MB. A human model of conjunctival healing. Invest Ophthalmol Visual Sci. 1991; 32(Suppl):1160.
  561. George MA, Smith LM, Abelson MB. Efficacy of 1.0% prednisolone sodium phosphate in alleviating the signs and symptoms of allergic conjunctivitis. Invest. Ophthalmol Visual Sci. 1991; 32(Suppl):736.
  562. Butrus SI, Ochsner KI, Abelson MB, Schwartz LB. The level of tryptase in human tears. An indicator of activation of conjunctival mast cells. Ophthalmology. 1990 Dec; 97(12):1678-83. PMID: 2087298.
    View in: PubMed
  563. Ormerod LD, Garsd A, Abelson MB, Kenyon KR. Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. Am J Pathol. 1990 Nov; 137(5):1243-52. PMID: 1700621; PMCID: PMC1877677.
  564. Abelson MB, Paradis A, George MA, Smith LM, Maguire L, Burns R. Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis. Arch Ophthalmol. 1990 Apr; 108(4):520-4. PMID: 2322153.
    View in: PubMed
  565. George MA, Smith LM, Berdy GJ, Abelson MB. Platelet activating factor induced inflammation following topical ocular challenge. Invest Ophthalmol Visual Sci. 1990; 31(Suppl):63.
  566. Abelson MB, Frangieh GT, Kas MA, Laibson PR, Lemp MA, Leopold IH, Puliafito CA, Steinert RF. Ophthalmology Pocket Reference. Allergan Pharmaceuticals. 1990.
  567. Rodriquez RD, Smith LM, George MA, Abelson MB. Recent advances in the therapy of ocular allergy. North American Clinics in Ophthalmology. 1990; 3:563-574.
  568. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol. 1990 Jan; 108(1):84-8. PMID: 2297337.
    View in: PubMed
  569. Bishop K, Abelson MB, Cheetham J, Harper D. . Evaluation of flurbiprofen in the treatment of antigen-induced allergic conjunctivitis. Invest Ophthalmol Visual Sci. 1990; 31(Suppl):487.
  570. Ormerod LD, Garsd A, Abelson MB, Kenyon KR. Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. Amer. J. Pathol. 1990; 137:5.
  571. Berdy GJ, Levene RB, Bateman ST, George MA, Smith LM, Abelson MB. Identification of histaminase activity in human tears after conjunctival antigen challenge. Invest Ophthalmol Visual Sci. 1990; 31(Suppl):65.
  572. Ormerod LD, Abelson MB, Kenyon KR. Standard models of corneal injury using alkali-immersed filter discs. Invest Ophthalmol Vis Sci. 1989 Oct; 30(10):2148-53. PMID: 2477342.
    View in: PubMed
  573. Ormerod LD, Garsd A, Reddy CV, Gomes SA, Abelson MB, Kenyon KR. Dynamics of corneal epithelial healing after an alkali burn. A statistical analysis. Invest Ophthalmol Vis Sci. 1989 Aug; 30(8):1784-93. PMID: 2759793.
    View in: PubMed
  574. Abelson MB, Mandel E, Paradis A, George M. The effect of hyaluronidase on akinesia during cataract surgery. Ophthalmic Surg. 1989 May; 20(5):325-6. PMID: 2726146.
    View in: PubMed
  575. Ormerod LD, Kavieff RD, Mallen PR, Abelson MB. Standardized recording of acute corneal disease. Ann Ophthalmol. 1989 May; 21(5):164-8. PMID: 2742288.
    View in: PubMed
  576. Singer A, Phillip M, Hermoni D, Abelson M, Moses SW. Correlation between C-reactive protein and throat culture results in patients with pharyngitis. Isr J Med Sci. 1989 Apr; 25(4):235-6. PMID: 2708029.
    View in: PubMed
  577. Trocmé SD, Gilbert CM, Allansmith MR, Bloch KJ, Abelson MB. Characteristics of the cellular response of the rat conjunctiva to topically applied leukotriene B4. Ophthalmic Res. 1989; 21(4):297-302. PMID: 2555760.
    View in: PubMed
  578. Abelson MB, Smith LM, Chambers W. The allergen challenge model of allergic conjunctivitis in 396 subjects. Ophthalmology. 1989; 96(9 Suppl):119.
  579. Udell IJ, Kenyon KR, Hanninen LA, Abelson MB. Time course of human conjunctival mast cell degranulation in response to compound 48/80. Acta Ophthalmol Suppl. 1989; 192:154-61. PMID: 2554645.
    View in: PubMed
  580. Butrus SI, Abelson MB. Lipid Mediators in Eye Inflammation. Bazan N, Karger AG, editors. New Trends in Lipid Mediator Research. 1989; 5.
  581. Gudmundsson OG, Ormerod LD, Kenyon KR, Glynn RJ, Baker AS, Haaf J, Lubars S, Abelson MB, Boruchoff SA, Foster CS, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989; 8(2):115-21. PMID: 2714094.
    View in: PubMed
  582. Abelson MB, Smith LM, Ormerod LD. Prospective, randomized trial of oral piroxicam in the prophylaxis of postoperative cystoid macular edema. J Ocul Pharmacol. 1989; 5(2):147-53. PMID: 2666532.
    View in: PubMed
  583. Abelson MB, Gilbert CM. Contact Lens Update. Princeton: Excerpta Medica. 1989.
  584. George M, Greiner JV, Conway J, Smith LM, Berdy GJ, Abelson MB. The effects of a new non-steroidal anti-inflammatory agent, 1% and 0.5% RMI1068, in an animal model of anterior uveitis. Invest Ophthalmol Visual Sci. 1989; 30(Suppl):84.
  585. Abelson MB, Smith LM. Levocabastine. Evaluation in the histamine and compound 48/80 models of ocular allergy in humans. Ophthalmology. 1988 Nov; 95(11):1494-7. PMID: 3211458.
    View in: PubMed
  586. Butrus SI, Abelson MB. Importance of limbal examination in ocular allergic disease. Ann Ophthalmol. 1988 Mar; 20(3):101-4. PMID: 3135773.
    View in: PubMed
  587. Abelson MB, Gilbert CM, Smith LM. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am J Ophthalmol. 1988 Feb 15; 105(2):155-9. PMID: 3341432.
    View in: PubMed
  588. Smith LM, Abelson MB. Rodocaine: a new local anesthetic for use in the eye. Invest Ophthalmol Visual Sci. 1988; 29(Suppl):454.
  589. Alfonso E, Abelson MB, Smith LM. Pharmacologic pupillary modulation in the perioperative period. J Cataract Refract Surg. 1988 Jan; 14(1):78-80. PMID: 3339553.
    View in: PubMed
  590. Butrus SI, Abelson MB. Laboratory evaluation of ocular allergy. Int Ophthalmol Clin. 1988; 28(4):324-8. PMID: 3053493.
    View in: PubMed
  591. Udell IJ, Ormerod LD, Boniuk V, Abelson MB. Treatment of contact lens-associated corneal erosions. Am J Ophthalmol. 1987 Sep 15; 104(3):306-7. PMID: 3631191.
    View in: PubMed
  592. Abelson MB, Rombaut N, Vanden Bussche G. Levocabastine: evaluation in human ocular histamine and 48/80 model. Allergologia E Immunologia Clinica. 1987; 2(3):281.
  593. Butrus SI, Weston JH, Abelson MB. Ocular mast cell stabilizing agents. Lamberts DW, Potter D, editors. Clinical Ophthalmic Pharmacology. 1987; 483-496.
  594. Abelson MB, Butrus SI, Kliman GH, Larson DL, Corey EJ, Smith LM. Topical arachidonic acid: a model for screening anti-inflammatory agents. J Ocul Pharmacol. 1987; 3(1):63-75. PMID: 3141537.
    View in: PubMed
  595. Weston JH, Abelson MB. Antihistamines. Lamberts DW, Potter D, editors. Clinical Ophthalmic Pharmacology. 1987; 417-424.
  596. Butrus SI, Abelson MB, Allansmith MR. Ocular Allergic Disorders. Lockey RF, Bukantz SC, editors. Principles of Immunology and Allergy. 1987; 165-176.
  597. Butrus SI, Abelson MB. Contact lenses and the allergic patient. Int Ophthalmol Clin. 1986; 26(1):73-81. PMID: 3949457.
    View in: PubMed
  598. Abelson MB, Alfonso E. Pupillary Modulation Update. Princeton: Excerpta Medica. 1986.
  599. Gilbert CM, Allansmith MR, Abelson MB. Geriatric ocular allergy. Geriatric Ophthalmology. 1986; 2(S):22-24.
  600. Weston JH, Abelson MB. Leukotriene C4 in rabbit and human eyes. Invest Ophthalmol Visual Sci. 1985; 26 (Suppl):191.
  601. Abelson MB, Weston JH. Mediators of ocular inflammation. Duane TD, Jaeger EA, editors. Biomedical Foundations of Ophthalmology. 1985.
  602. Abelson MB, Baker AS, Weston JH. Ophthalmic Antibiotic Update. Princeton: Excerpta Medica. 1985.
  603. Abelson MB, Madiwale NA, Weston JH. The role of prostaglandin D2 in allergic ocular disease. Advances in Immunology and Immunopathology of the Eye. 1985; 163-166.
  604. Butrus SI, Puliafito C, Abelson MB. Screening of anti inflammatory agents in a laser model. Invest Ophthalmol Visual Sci. 1985; 26 (Suppl):192.
  605. Butrus SI, Abelson MB. Mucous membrane grafting for severe palpebral vernal conjunctivitis. Arch Ophthalmol. 1984 Dec; 102(12):1746, 1748. PMID: 6508608.
    View in: PubMed
  606. Abelson MB, Butrus SI, Weston JH, Rosner B. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage. Ophthalmology. 1984 Nov; 91(11):1364-7. PMID: 6514304.
    View in: PubMed
  607. Butrus SI, Leung DY, Gellis S, Baum J, Kenyon KR, Abelson MB. Vernal conjunctivitis in the hyperimmunoglobulinemia E syndrome. Ophthalmology. 1984 Oct; 91(10):1213-6. PMID: 6240007.
    View in: PubMed
  608. Butrus SI, Corey EJ, Weston JH, Abelson MB. The effect of leukotriene B4 in rabbit and guinea pig eyes. Invest Ophthalmol Visual Sci. 1984; 25 (Suppl):109.
  609. Kenyon KR, Abelson MB. Hydrogel keratophakia. Jakobiec FA, Sigelman J, editors. Advanced Techniques in Ocular Surgery. 1984; 53-60.
  610. Weston JH, Corey EJ, Butrus SI, Abelson MB. The human conjunctiva and arachidonic acid. Invest Ophthalmol Visual Sci. 1984; 25 (Suppl):109.
  611. Abelson MB. Lipoxygenase products in ocular inflammation. Invest Ophthalmol Visual Sci. 1984; 25(Suppl):42.
  612. Sendele DD, Abelson MB, Kenyon KR, Hanninen LA. Intracorneal lens implantation. Arch Ophthalmol. 1983 Jun; 101(6):940-4. PMID: 6860210.
    View in: PubMed
  613. Abelson MB, Udell IJ, Weston JH. Conjunctival eosinophils in compound 48/80 rabbit model. Arch Ophthalmol. 1983 Apr; 101(4):631-3. PMID: 6838424.
    View in: PubMed
  614. Abelson MB, Madiwale N, Weston JH. Conjunctival eosinophils in allergic ocular disease. Arch Ophthalmol. 1983 Apr; 101(4):555-6. PMID: 6838412.
    View in: PubMed
  615. Abelson MB, Butrus SI, Weston JH. Aspirin therapy in vernal conjunctivitis. Am J Ophthalmol. 1983 Apr; 95(4):502-5. PMID: 6573138.
    View in: PubMed
  616. Abelson MB, Butrus SI, Weston JH. Thimerosal Update. Princeton: Excerpta Medica. 1983.
  617. Abelson MB, Lamberts DW. Dry Eye Update. Princeton: Excerpta Medica. 1983.
  618. Sendele DD, Abelson MB. An evaluation of new polymers in intracorneal lens implants. Schachar RA, Levy NS, Schachar L, editors. Refractive Keratoplasty. 1983; 64-73.
  619. Udell IJ, Abelson MB. Chemical mediators of inflammation. Int Ophthalmol Clin. 1983; 23(1):15-26. PMID: 6826299.
    View in: PubMed
  620. Abelson MB, Ganley J. The American Academy of Ophthalmology and Radial Keratotomy. Schachar RA, Levy NS, Schachar L, editors. Refractive Keratoplasty. 1983; 152-155.
  621. Butrus SI, Weston JH, Abelson MB. Effects of alpha-adrenergic blockers and zinc sulfate in the eye. Invest Ophthalmol Visual Sci. 1983; 24 (Suppl):1.
  622. Allansmith MR, Abelson MB. . Ocular allergies. Smolin G, Thoft RA, editors. The Cornea. 1983; 231-243.
  623. Galbavy E, Weston JH, Abelson MB. Cyanoacrylate-supported corneal incisions - a method of refractive keratoplasty?. Invest Ophthalmol Visual Sci. 1982; 22 (Suppl):29.
  624. Abelson MB. Thimerosal. Immunological aspects of contact lenses, Mid-Winter National Meeting of Contact Lens Association of Ophthalmologists. 1982.
  625. Udell IJ, Gleich GJ, Allansmith MR, Ackerman SJ, Abelson MB. Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears. Am J Ophthalmol. 1981 Dec; 92(6):824-8. PMID: 7315934.
    View in: PubMed
  626. Abelson MB, Udell IJ, Weston JH. Standardization of ocular surface injection intensity. Ann Ophthalmol. 1981 Oct; 13(10):1225. PMID: 7316348.
    View in: PubMed
  627. Abelson MB, Udell IJ, Weston JH. Normal human tear pH by direct measurement. Arch Ophthalmol. 1981 Feb; 99(2):301. PMID: 7469869.
    View in: PubMed
  628. Abelson MB, Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol. 1981 Feb; 99(2):302-4. PMID: 6451212.
    View in: PubMed
  629. Udell IJ, Abelson MB. Animal and human ocular surface response to a topical nonimmune mast-cell degranulating agent (compound 48/80). Am J Ophthalmol. 1981 Feb; 91(2):226-30. PMID: 6162389.
    View in: PubMed
  630. Abelson MB. Immunologicial aspects. Interaction of corneal epithelium, tear film, and the contact lens, Mid-Winter National Meeting of Contact Lens Association of Ophthalmologists. 1981.
  631. Abelson MB, Udell IJ. Ocular Allergy Update. Princeton: Excerpta Medica. 1981.
  632. Abelson MB. Immunologicial aspects. Symposium: Interaction of corneal epithelium, tear film, and the contact lens, Mid-Winter National Meeting of Contact Lens Association of Ophthalmologists. 1981.
  633. Abelson, MB. The role of saline and enzymatic cleaners in the care of soft lenses. Symposium: Hygienic Care of Soft Lenses, Mid-Winter National Meeting of Contact Lens Association of Ophthalmologists. 1981.
  634. Abelson MB. Accomplishments of the Keratorefractive Society. Schachar RA, Levy NS, Schachar L, editors. Refractive Modulation of the Cornea - Proceedings of the Annual Keratorefractive Society Meeting on Radial Keratotomy and Kerato-refraction. 1981; 1-5.
  635. Weston JH, Udell IJ, Abelson MB. H1 receptors in the human ocular surface. Invest Ophthalmol Visual Sci. 1981; 20 (Suppl):32.
  636. Abelson MB, Sadun AA, Udell IJ, Weston JH. Alkaline tear pH in ocular rosacea. Am J Ophthalmol. 1980 Dec; 90(6):866-9. PMID: 6449875.
    View in: PubMed
  637. Abelson MB, Collin HB, Gillette TE, Dohlman CH. Recurrent keratoconus after keratoplasty. Am J Ophthalmol. 1980 Nov; 90(5):672-6. PMID: 7004192.
    View in: PubMed
  638. Allansmith MR, Baird RS, Higgenbotham EJ, Abelson MB. Technical aspects of histamine determination in human tears. Am J Ophthalmol. 1980 Nov; 90(5):719-24. PMID: 7446654.
    View in: PubMed
  639. Abelson MB, Baird RS, Allansmith MR. Tear histamine levels in vernal conjunctivitis and other ocular inflammations. Ophthalmology. 1980 Aug; 87(8):812-4. PMID: 7443214.
    View in: PubMed
  640. Abelson MB, Allansmith MR, Friedlaender MH. Effects of topically applied occular decongestant and antihistamine. Am J Ophthalmol. 1980 Aug; 90(2):254-7. PMID: 7425039.
    View in: PubMed
  641. Abelson MB, Yamamoto GK, Allansmith MR. Effects of ocular decongestants. Arch Ophthalmol. 1980 May; 98(5):856-8. PMID: 7378008.
    View in: PubMed
  642. Gillette TE, Udell IJ, Abelson MB. Hydrogel keratophakia. Keratorefraction. 1980; 13:127-134.
  643. Abelson MB. Ocular allergy in contact lens wearers. Symposium on Tears and Contact Lenses, Mid-Winter National Meeting of Contact Lens Association of Ophthalmologists. 1980.
  644. Abelson MB. The controversy of radial keratotomy. Proceedings of the Semi-annual Keratorefractive Society Meeting on Controversial Aspects of Radial Keratotomy. 1980; 1-3.
  645. Abelson MB, Allansmith MR. Histamine and the eye. Immunology and Immunopathology of the Eye. 1979; 65:362-364.
  646. Abelson MB, Yamamoto GK, Higgenbotham EJ, Allansmith MR. Model of ocular allergy produced by local histamine. Association for Research in Vision and Ophthalmology. 1979.
  647. Pavan-Langston D, Abelson MB. Glucocorticoid therapy in ocular herpes simplex. II. Advantages. Surv Ophthalmol. 1978 Jul-Aug; 23(1):35, 43-7. PMID: 568322.
    View in: PubMed
  648. Pavan-Langston D, Abelson MB. Glucocorticoid therapy in ocular herpes simplex. II. Advantages. 1978; 23(35):43-48.
  649. Abelson MB, Holly FJ. A tentative mechanism for inferior punctate keratopathy. Am J Ophthalmol. 1977 Jun; 83(6):866-9. PMID: 868989.
    View in: PubMed
  650. Abelson MB, Soter NA, Simon MA, Dohlman J, Allansmith MR. Histamine in human tears. Am J Ophthalmol. 1977 Mar; 83(3):417-8. PMID: 848549.
    View in: PubMed
  651. Pavan-Langston D, Abelson MB. The role of steroids in ocular herpes. Boruchoff SA, Hutchinson BT, Brockhurst R, editors. Controversies in Ophthalmology. 1977; III(16):438-449.
  652. Abelson MB, Pavan-Langston D. Viral uveitis. Int Ophthalmol Clin. 1977; 17(3):109-20. PMID: 197040.
    View in: PubMed
  653. Allansmith MR, Kajiyama G, Abelson MB, Simon MA. Plasma cell content of main and accessory lacrimal glands and conjunctiva. Am J Ophthalmol. 1976 Dec; 82(6):819-26. PMID: 998699.
    View in: PubMed
  654. Collin HB, Abelson MB. Herpes simplex virus in human cornea, retrocorneal fibrous membrane, and vitreous. Arch Ophthalmol. 1976 Oct; 94(10):1726-9. PMID: 184770.
    View in: PubMed
  655. Abelson MB, Allansmith MR. Normal conjunctival wound edge flora of patients undergoing uncomplicated cataract extraction. Am J Ophthalmol. 1973 Oct; 76(4):561-5. PMID: 4582796.
    View in: PubMed
  656. Abelson MB. Tear immunoglobulins. Association for Research in Vision and Ophthalmology. Tear Symposium. 1973.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Abelson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description